UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL people

Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Type | Date
Number of items: 763.

Article

Hobart, JC; Williams, LS; Moran, K; Thompson, AJ; (2002) Quality of life measurement after stroke - Uses and abuses of the SF-36. STROKE , 33 (5) 1348 - 1356. 10.1161/01.STR.0000015030.59594.B3.

Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2003) Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales. MULT SCLER J , 9 (4) 411 - 419. 10.1191/1352458503ms929oa.

Hobart, JC; Thompson, AJ; (2001) The five item Barthel index. J NEUROL NEUROSUR PS , 71 (2) 225 - 230.

Aguirregomozcorta, M; Mancini, L; Jenkins, TM; Hickman, SJ; Ciccarelli, O; Plant, GT; ... Toosy, AT; + view all (2011) A longitudinal functional MRI study of non-arteritic anterior ischaemic optic neuropathy patients. J NEUROL NEUROSUR PS , 82 (8) 905 - 913. 10.1136/jnnp.2009.194563.

Altmann, DR; Jasperse, B; Barkhof, F; Beckmann, K; Filippi, M; Kappos, LD; ... Miller, DH; + view all (2009) Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. NEUROLOGY , 72 (7) 595 - 601.

Altmann, DR; Miszkiel, KA; Thompson, AJ; (2009) Gray Matter Atrophy Is Related to Long-Term Disability in Multiple Sclerosis (vol 64, pg 247, 2008). ANN NEUROL , 65 (2) 232 - 232. 10.1002/ana.21570.

Amato, MP; Grimaud, J; Achiti, I; Bartolozzi, ML; Adeleine, P; Hartung, HP; ... EDMUS System EVALUED Study Grp,; + view all (2004) European validation of a standardized clinical description of multiple sclerosis. J NEUROL , 251 (12) 1472 - 1480. 10.1007/s00415-004-0567-0.

Anderson, VM; Fisniku, LK; Altmann, DR; Thompson, AJ; Miller, DH; (2009) MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction. MULT SCLER , 15 (7) 811 - 817. 10.1177/1352458508101934.

Anderson, VM; Fisniku, LK; Khaleeli, Z; Summers, MM; Penny, SA; Altmann, DR; ... Miller, DH; + view all (2010) Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study. MULT SCLER , 16 (9) 1083 - 1090. 10.1177/1352458510374893.

Anderson, VM; Wheeler-Kingshott, CAM; Abdel-Aziz, K; Miller, DH; Toosy, A; Thompson, AJ; Ciccarelli, O; (2011) A comprehensive assessment of cerebellar damage in multiple sclerosis using diffusion tractography and volumetric analysis. MULT SCLER J , 17 (9) 1079 - 1087. 10.1177/1352458511403528.

Antel, J; Carroll, W; Thompson, A; (2008) Untitled. MULT SCLER , 14 (9) 1153 - 1153. 10.1177/1352458508098093.

Antel, J; Thompson, A; Carroll, W; (2010) Chronic cerebrospinal venous insufficiency. MULT SCLER , 16 (7) 770 - 770. 10.1177/1352458510374342.

Audoin, B; Davies, G; Rashid, W; Fisniku, L; Thompson, AJ; Miller, DH; (2007) Voxel-based analysis of grey matter magnetization transfer ratio maps in early relapsing remitting multiple sclerosis. MULT SCLER , 13 (4) 483 - 489. 10.1177/1352458506070450.

Audoin, B; Davies, GR; Finisku, L; Chard, DT; Thompson, AJ; Miller, DH; (2006) Localization of grey matter atrophy in early RRMS - A longitudinal study. J NEUROL , 253 (11) 1495 - 1501. 10.1007/s00415-006-0264-2.

Audoin, B; Fernando, KTM; Swanton, JK; Thompson, AJ; Plant, GT; Miller, DH; (2006) Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis. BRAIN , 129 1031 - 1039. 10.1093/brain/awl039.

Baker, D; Pryce, G; Giovannoni, G; Thompson, AJ; (2003) The therapeutic potential of cannabis. LANCET NEUROL , 2 (5) 291 - 298.

Bakshi, R; Thompson, AJ; Rocca, MA; Pelletier, D; Dousset, V; Barkhof, F; ... Filippi, M; + view all (2008) MRI in multiple sclerosis: current status and future prospects. LANCET NEUROL , 7 (7) 615 - 625.

Barkhof, F; Filippi, M; Miller, DH; Tofts, P; Kappos, L; Thompson, AJ; (1997) Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. J NEUROL , 244 (2) 76 - 84.

BARKHOF, F; THOMPSON, AJ; KAPPOS, L; NAUTA, JJP; YOUSRI, T; BERRY, I; ... MILLER, DH; + view all (1993) DATABASE FOR SERIAL MAGNETIC-RESONANCE-IMAGING IN MULTIPLE-SCLEROSIS. NEURORADIOLOGY , 35 (5) 362 - 366.

Barkhof, F; van Waesberghe, JHTM; Filippi, M; Yousry, T; Miller, DH; Hahn, D; ... European Study Grp Interferon beta,; + view all (2001) T-1 hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment. BRAIN , 124 1396 - 1402.

BARRY, R; LAWRENCE, M; THOMPSON, A; MCDONALD, I; GROOME, N; (1990) AN IMPROVED RADIOIMMUNOASSAY FOR MYELIN BASIC PROTEIN-LIKE IMMUNOREACTIVE MATERIAL IN CEREBROSPINAL-FLUID. NEUROCHEM INT , 16 (4) 549 - 558.

Behrens, T.E.J.; Johansen-Berg, H.; Woolrich, M.W.; Smith, S.M.; Wheeler-Kingshott, C.A.M.; Boulby, P.A.; ... Matthews, P.M.; + view all (2003) Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. Nature Neuroscience , 6 (7) pp. 750-757. 10.1038/nn1075.

Behrens, TEJ; Johansen-Berg, H; Woolrich, MW; Smith, SM; Wheeler-Kingshott, CAM; Boulby, PA; ... Matthews, PM; + view all (2003) Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging. NAT NEUROSCI , 6 (7) 750 - 757. 10.1038/nn1075.

Bieniek, M; Altmann, DR; Davies, GR; Ingle, GT; Rashid, W; Sastre-Garriga, J; ... Miller, DH; + view all (2006) Cord atrophy separates early primary progressive and relapsing remitting multiple sclerosis. J NEUROL NEUROSUR PS , 77 (9) 1036 - 1039. 10.1136/jnnp.2006.094748. Gold open access

Bodini, B; Battaglini, M; De Stefano, N; Khaleeli, Z; Barkhof, F; Chard, D; ... Ciccarelli, O; + view all (2011) T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis. J NEUROL NEUROSUR PS , 82 (1) 72 - 77. 10.1136/jnnp.2009.201574. Gold open access

Bodini, B; Cercignani, M; Khaleeli, Z; Miller, DH; Ron, M; Penny, S; ... Ciccarelli, O; + view all (2013) Corpus callosum damage predicts disability progression and cognitive dysfunction in primary-progressive MS after five years. Hum Brain Mapp , 34 (5) 1163 - 1172. 10.1002/hbm.21499.

Bodini, B; Cercignani, M; Toosy, A; De Stefano, N; Miller, DH; Thompson, AJ; Ciccarelli, O; (2014) A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS. Hum Brain Mapp , 35 (2) 723 - 733. 10.1002/hbm.22196.

Bodini, B; Khaleeli, Z; Cercignani, M; Miller, DH; Thompson, AJ; Ciccarelli, O; (2009) Exploring the Relationship Between White Matter and Gray Matter Damage in Early Primary Progressive Multiple Sclerosis: An In Vivo Study With TBSS and VBM. HUM BRAIN MAPP , 30 (9) 2852 - 2861. 10.1002/hbm.20713.

Bonati, U; Fisniku, LK; Altmann, DR; Yiannakas, MC; Furby, J; Thompson, AJ; ... Chard, DT; + view all (2011) Cervical cord and brain grey matter atrophy independently associate with long-term MS disability. J NEUROL NEUROSUR PS , 82 (4) 471 - 472.

Bosma, LVAE; Kragt, JJ; Brieva, L; Khaleeli, Z; Montalban, X; Polman, CH; ... Uitdehaag, BMJ; + view all (2010) Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components? MULT SCLER , 16 (7) 862 - 867. 10.1177/1352458510370464.

Bosma, LVAE; Kragt, JJ; Brieva, L; Khaleeli, Z; Montalban, X; Polman, CH; ... Uitdehaag, BMJ; + view all (2009) The search for responsive clinical endpoints in primary progressive multiple sclerosis. MULT SCLER , 15 (6) 715 - 720. 10.1177/1352458509102626.

Bosnell, R; Wegner, C; Kincses, ZT; Korteweg, T; Agosta, F; Ciccarelli, O; ... Matthews, PM; + view all (2008) Reproducibility of fMRI in the clinical setting: Implications for trial designs. NEUROIMAGE , 42 (2) 603 - 610. 10.1016/j.neuroimage.2008.05.005.

Brex, P.A.; Ciccarelli, O.; O'Riordan, J.I.; Sailer, M.; Thompson, A.J.; Miller, D.H.; (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. New England Journal of Medicine , 346 (3) pp. 158-164. 10.1056/NEJMoa011341. Green open access
file

Brex, PA; Ciccarelli, O; O'Riordan, JI; Sailer, M; Thompson, AJ; Miller, DH; (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. NEW ENGL J MED , 346 (3) 158 - 164.

Brex, PA; Ciccarelli, O; O'Riordan, JI; Sailer, M; Thompson, AJ; Miller, DH; (2001) Relation between serial MRI and the development of disability in patients with clinically isolated syndromes suggestive of multiple sclerosis. J NEUROL NEUROSUR PS , 71 (3) 423 - 423.

Brex, PA; Leary, SM; O'Riordan, JI; Miszkiel, KA; Plant, GT; Thompson, AJ; Miller, DH; (2001) Measurement of spinal cord area in clinically isolated syndromes suggestive of multiple sclerosis. J NEUROL NEUROSUR PS , 70 (4) 544 - 547.

Brex, PA; Leary, SM; Plant, GT; Thompson, AJ; Miller, DH; (2001) Magnetization transfer imaging in patients with clinically isolated syndromes suggestive of multiple sclerosis. AM J NEURORADIOL , 22 (5) 947 - 951.

Brex, PA; Miszkiel, KA; O'Riordan, JI; Plant, GT; Moseley, IF; Thompson, AJ; Miller, DH; (2001) Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI. J NEUROL NEUROSUR PS , 70 (3) 390 - 393.

Brex, PA; Molyneux, PD; Smiddy, P; Barkhof, F; Filippi, M; Yousry, TA; ... European Study Grp Interferon beta,; + view all (2001) The effect of IFN beta-1b on the evolution of enhancing lesions in secondary progressive MS. NEUROLOGY , 57 (12) 2185 - 2190.

Brex, PA; O'Riordan, JI; Miszkiel, KA; Moseley, IF; Thompson, AJ; Plant, GT; Miller, DH; (1999) Multisequence MRI in clinically isolated syndromes and the early development of MS. NEUROLOGY , 53 (6) 1184 - 1190.

Brex, PA; Parker, GJM; Leary, SM; Molyneux, PD; Barker, GJ; Davie, CA; ... Miller, DH; + view all (2000) Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations. J NEUROL NEUROSUR PS , 68 (5) 627 - 632.

Brown, MM; Thompson, AJ; Goh, BT; Forster, GE; Swash, M; (1988) Bell's palsy and HIV infection. Journal of Neurology, Neurosurgery and Psychiatry , 51 425 - 426.

BROWN, MM; THOMPSON, AJ; WEDZICHA, JA; SWASH, M; (1989) SARCOIDOSIS PRESENTING WITH STROKE. STROKE , 20 (3) 400 - 405.

CADOUXHUDSON, TAD; KERMODE, A; RAJAGOPALAN, B; TAYLOR, D; THOMPSON, AJ; ORMEROD, IEC; ... RADDA, GK; + view all (1991) BIOCHEMICAL-CHANGES WITHIN A MULTIPLE-SCLEROSIS PLAQUE INVIVO. J NEUROL NEUROSUR PS , 54 (11) 1004 - 1006.

Camp, SJ; Stevenson, VL; Thompson, AJ; Ingle, GT; Miller, DH; Borras, C; ... Langdon, DW; + view all (2005) A longitudinal study of cognition in primary progressive multiple sclerosis. BRAIN , 128 2891 - 2898. 10.1093/brain/awh602.

Camp, SJ; Stevenson, VL; Thompson, AJ; Miller, DH; Borras, C; Auriacombe, S; ... Langdon, DW; + view all (1999) Cognitive function in primary progressive and transitional progressive multiple sclerosis - A controlled study with MRI correlates. BRAIN , 122 1341 - 1348.

Camp, SJ; Thompson, AJ; Langdon, DW; (2001) A new test of memory for multiple sclerosis I: Format development and stimuli design. MULT SCLER , 7 (4) 255 - 262.

Cano, SJ; Hobart, JC; Edwards, M; Fitzpatrick, R; Bhatia, K; Thompson, AJ; Warner, TT; (2006) CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia. NEUROLOGY , 67 (12) 2230 - 2232.

Cano, SJ; Hobart, JC; Fitzpatrick, R; Bhatia, K; Thompson, AJ; Warner, TT; (2004) Patient-based outcomes of cervical dystonia: A review of rating scales. MOVEMENT DISORD , 19 (9) 1054 - 1059. 10.1002/mds.20055.

Cano, SJ; O'Connor, RJ; Thompson, AJ; Hobart, JC; (2006) Exploring disability rating scale responsiveness II: Do more response options help? NEUROLOGY , 67 (11) 2056 - 2059.

Cano, SJ; Thompson, AJ; Bhatia, K; Fitzpatrick, R; Warner, TT; Hobart, JC; (2007) Evidence-based guidelines for using the short form 36 in cervical dystonia. MOVEMENT DISORD , 22 (1) 122 - 126. 10.1002/mds.21187.

Cano, SJ; Warner, TT; Linacre, JM; Bhatia, KP; Thompson, AJ; Fitzpatrick, R; Hobart, JC; (2004) Capturing the true burden of dystonia on patients - The Cervical Dystonia Impact Profile (CDIP-58). NEUROLOGY , 63 (9) 1629 - 1633.

Cano, SJ; Warner, TT; Thompson, AJ; Bhatia, KP; Fitzpatrick, R; Hobart, JC; (2008) The Cervical Dystonia Impact Profile (CDIP-58): Can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria? HEALTH QUAL LIFE OUT , 6 , Article 58. 10.1186/1477-7525-6-58. Gold open access

Chard, DT; Brex, PA; Ciccarelli, O; Griffin, CM; Parker, GJM; Dalton, C; ... Miller, DH; + view all (2003) The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study. J NEUROL NEUROSUR PS , 74 (11) 1551 - 1554.

Chard, DT; Brex, PA; Ciccarelli, O; Griffin, CMB; Dalton, C; Thompson, AJ; Miller, DH; (2002) The predictive value of brain lesion load in determining brain atrophy in multiple sclerosis: 14 year follow up data following first presentation with a clinically isolated syndrome. J NEUROL NEUROSUR PS , 73 (2) 214 - 214.

Chard, DT; Dalton, CM; Swanton, J; Fisniku, LK; Miszkiel, KA; Thompson, AJ; ... Miller, DH; + view all (2011) MRI only conversion to multiple sclerosis following a clinically isolated syndrome. J NEUROL NEUROSUR PS , 82 (2) 176 - 179. 10.1136/jnnp.2010.208660.

Chard, DT; Griffin, CM; McLean, MA; Kapeller, P; Kapoor, R; Thompson, AJ; Miller, DH; (2002) Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. BRAIN , 125 2342 - 2352.

Chard, DT; Griffin, CM; Parker, GJM; Kapoor, R; Thompson, AJ; Miller, DH; (2002) Brain atrophy in clinically early relapsing-remitting multiple sclerosis. BRAIN , 125 327 - 337.

Chard, DT; Griffin, CM; Rashid, W; Davies, GR; Altmann, DR; Kapoor, R; ... Miller, DH; + view all (2004) Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. MULT SCLER , 10 (4) 387 - 391. 10.1191/1352458504ms1050oa.

Chard, DT; Parker, GJM; Griffin, CMB; Thompson, AJ; Miller, DH; (2002) The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology. JOURNAL OF MAGNETIC RESONANCE IMAGING , 15 (3) 259 - 267. 10.1002/jmri.10064.

Chataway, J; Porter, B; Riazi, A; Heaney, D; Watt, H; Hobart, J; Thompson, A; (2006) Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial. LANCET NEUROL , 5 (7) 565 - 571. 10.1016/S1474-4422(06)70450-1.

Chataway, J.; Porter, B.; Riazi, A.; Heaney, D.; Watt, H.; Hobart, J.; Thompson, A.; (2006) Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trial. The Lancet Neurology , 5 (7) pp. 565-571. 10.1016/S1474-4422(06)70450-1.

Ciccarelli, O; Altmann, DR; McLean, MA; Wheeler-Kingshott, CA; Wimpey, K; Miller, DH; Thompson, AJ; (2010) Spinal cord repair in MS Does mitochondrial metabolism play a role? NEUROLOGY , 74 (9) 721 - 727. 10.1212/WNL.0b013e3181d26968. Gold open access

Ciccarelli, O; Behrens, TE; Altmann, DR; Orrell, RW; Howard, RS; Johansen-Berg, H; ... Thompson, AJ; + view all (2006) Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis. BRAIN , 129 1859 - 1871. 10.1093/brain/awl100.

Ciccarelli, O; Behrens, TE; Johansen-Berg, H; Talbot, K; Orrell, RW; Howard, RS; ... Smith, SM; + view all (2009) Investigation of White Matter Pathology in ALS and PLS Using Tract-Based Spatial Statistics. HUM BRAIN MAPP , 30 (2) 615 - 624. 10.1002/hbm.20527.

Ciccarelli, O; Brex, PA; Thompson, AJ; Miller, DH; (2002) Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR. J NEUROL , 249 (1) 18 - 24.

Ciccarelli, O; Catani, M; Johansen-Berg, H; Clark, C; Thompson, A; (2008) Diffusion-based tractography in neurological disorders: concepts, applications, and future developments. LANCET NEUROL , 7 (8) 715 - 727.

Ciccarelli, O; Parker, GJM; Toosy, AT; Wheeler-Kingshott, CAM; Barker, GJ; Boulby, PA; ... Thompson, AJ; + view all (2003) From diffusion tractography to quantitative white matter tract measures: a reproducibility study. NEUROIMAGE , 18 (2) 348 - 359. 10.1016/S1053-8119(02)00042-3.

Ciccarelli, O; Thomas, DL; De Vita, E; Wheeler-Kingshott, CA; Kachramanoglou, C; Kapoor, R; ... Thompson, AJ; + view all (2013) Low Myo-inositol indicating astrocytic damage in a case series of neuromyelitis optica. Ann Neurol , 74 (2) 301 - 305. 10.1002/ana.23909.

Ciccarelli, O; Toosy, AT; De Stefano, N; Wheeler-Kingshott, CAM; Miller, DH; Thompson, AJ; (2010) Assessing Neuronal Metabolism In Vivo by Modeling Imaging Measures. J NEUROSCI , 30 (45) 15030 - 15033. 10.1523/JNEUROSCI.3330-10.2010.

Ciccarelli, O; Toosy, AT; Hickman, SJ; Parker, GJM; Wheeler-Kingshott, CAM; Miller, DH; Thompson, AJ; (2005) Optic radiation changes after optic neuritis detected by tractography-based group mapping. HUM BRAIN MAPP , 25 (3) 308 - 316. 10.1002/hbm.20101.

Ciccarelli, O; Toosy, AT; Marsden, JE; Wheeler-Kingshott, CM; Miller, DH; Matthews, PM; Thompson, AJ; (2006) Functional response to active and passive ankle movements with clinical correlations in patients with primary progressive multiple sclerosis. J NEUROL , 253 (7) 882 - 891. 10.1007/s00415-006-0125-z.

Ciccarelli, O; Toosy, AT; Marsden, JF; Wheeler-Kingshott, CM; Sahyoun, C; Matthews, PM; ... Thompson, AJ; + view all (2005) Identifying brain regions for integrative sensorimotor processing with ankle movements. EXP BRAIN RES , 166 (1) 31 - 42. 10.1007/s00221-005-2335-5.

Ciccarelli, O; Toosy, AT; Parker, GJM; Wheeler-Kingshott, CAM; Barker, GJ; Miller, DH; Thompson, AJ; (2003) Diffusion tractography based group mapping of major white-matter pathways in the human brain. NEUROIMAGE , 19 (4) 1545 - 1555. 10.1016/S1053-8119(03)00190-3.

Ciccarelli, O; Werring, DJ; Barker, GJ; Griffin, CM; Wheeler-Kingshott, CAM; Miller, DH; Thompson, AJ; (2003) A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging - Evidence of Wallerian degeneration. J NEUROL , 250 (3) 287 - 292. 10.1007/s00415-003-0992-5.

Ciccarelli, O; Werring, DJ; Wheeler-Kingshott, CAM; Barker, GJ; Parker, GJM; Thompson, AJ; Miller, DH; (2001) Investigation of MS normal-appearing brain using diffusion tenser MRI with clinical correlations. NEUROLOGY , 56 (7) 926 - 933.

Ciccarelli, O; Wheeler-Kingshott, CA; McLean, MA; Cercignani, M; Wimpey, K; Miller, DH; Thompson, AJ; (2007) Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. BRAIN , 130 2220 - 2231. 10.1093/brain/awm152.

Clark, M; Playford, ED; Thompson, AJ; (2006) Adolescent neurorehabilitation. DEV MED CHILD NEUROL , 48 20 - 20.

Cockburn, F; Barwell, BE; Brenton, DP; Chapple, J; Clark, B; Curzon, G; ... Whittle, MJ; + view all (1993) Phenylketonuria due to phenylalanine hydroxylase deficiency:an unfolding story. BMJ (Clinical Research Ed.) , 306 115 - 119.

Cockburn, F; Barwell, BE; Breton, DP; Chapple, J; Clark, B; Curzon, G; ... Whittle, MJ; + view all (1993) Recommendations on the dietary management of phenylketonuria. Archives of Disease in Childhood , 68 426 - 427.

Cohen, JA; Reingold, SC; Polman, CH; Wolinsky, JS; Int Adv Cmmttee on Clinical Trials in MS,; (2012) Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects. Lancet Neurology , 11 (5) 467 - 476. 10.1016/S1474-4422(12)70059-5.

CONFAVREUX, C; COMPSTON, DAS; HOMMES, OR; MCDONALD, WI; THOMPSON, AJ; (1992) EDMUS, A EUROPEAN DATABASE FOR MULTIPLE-SCLEROSIS. J NEUROL NEUROSUR PS , 55 (8) 671 - 676.

Confavreux, C; Hutchinson, M; Hours, MM; Cortinovis-Tourniaire, P; Moreau, T; Pregnancy Multiple Sclerosis Grp,; (1998) Rate of pregnancy-related relapse in multiple sclerosis. NEW ENGL J MED , 339 (5) 285 - 291.

Connick, P; Kolappan, M; Crawley, C; Webber, DJ; Patani, R; Michell, AW; ... Chandran, S; + view all (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol , 11 (2) 150 - 156. 10.1016/S1474-4422(11)70305-2.

Connick, P; Kolappan, M; Patani, R; Scott, MA; Crawley, C; He, XL; ... Chandran, S; + view all (2011) The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments. TRIALS , 12 , Article 62. 10.1186/1745-6215-12-62. Gold open access

Cook, PA; Zhang, H; Avants, BB; Yushkevich, P; Alexander, DC; Gee, JC; ... Thompson, AJ; + view all (2005) An automated approach to connectivity-based partitioning of brain structures. Med Image Comput Assist Interv , 8 (1) 164 - 171.

Costelloe, L; Thompson, A; Walsh, C; Tubridy, N; Hutchinson, M; (2008) Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease. J NEUROL NEUROSUR PS , 79 (11) 1245 - 1248. 10.1136/jnnp.2008.143586.

Cutter, GR; Baier, ML; Rudick, RA; Cookfair, DL; Fischer, JS; Petkau, J; ... Willoughby, E; + view all (1999) Development of a multiple sclerosis functional composite as a clinical trial outcome measure. BRAIN , 122 871 - 882.

Dalton, CM; Bodini, B; Samson, RS; Battaglini, M; Fisniku, LK; Thompson, AJ; ... Chard, DT; + view all (2012) Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler , 18 (3) 322 - 328. 10.1177/1352458511420269.

Dalton, CM; Brex, PA; Jenkins, R; Fox, NC; Miszkiel, KA; Crum, WR; ... Miller, DH; + view all (2002) Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis. J NEUROL NEUROSUR PS , 73 (2) 141 - 147.

Dalton, CM; Brex, PA; Miszkiel, KA; Fernando, K; MacManus, DG; Plant, GT; ... Miller, DH; + view all (2003) Spinal cord MRI in clinically isolated optic neuritis. J NEUROL NEUROSUR PS , 74 (11) 1577 - 1580.

Dalton, CM; Brex, PA; Miszkiel, KA; Fernando, K; MacManus, DG; Plant, GT; ... Miller, DH; + view all (2003) New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. ANN NEUROL , 53 (5) 673 - 676. 10.1002/ana.10580.

Dalton, CM; Brex, PA; Miszkiel, KA; Hickman, SJ; MacManus, DG; Plant, GT; ... Miller, DH; + view all (2002) Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. ANN NEUROL , 52 (1) 47 - 53. 10.1002/ana.10240.

Dalton, CM; Brex, PA; Miszkiel, KA; Plant, GT; Hickman, SJ; MacManus, DG; ... Miller, DH; + view all (2002) Validation of the McDonald criteria in patients with clinically isolated syndromes. J NEUROL NEUROSUR PS , 73 (2) 214 - 214.

Dalton, CM; Chard, DT; Davies, GR; Miszkiel, KA; Altmann, DR; Fernando, K; ... Miller, DH; + view all (2004) Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. BRAIN , 127 1101 - 1107. 10.1093/brain/awh126.

Davie, CA; Barker, GJ; Thompson, AJ; Tofts, PS; McDonald, WI; Miller, DH; (1997) H-1 magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J NEUROL NEUROSUR PS , 63 (6) 736 - 742.

Davie, CA; Barker, GJ; Webb, S; Tofts, PS; Thompson, AJ; Harding, AE; ... Miller, DH; + view all (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. BRAIN , 118 1583 - 1592.

Davie, CA; Silver, NC; Barker, GJ; Tofts, PS; Thompson, AJ; McDonald, WI; Miller, DW; (1999) Does the extent of axonal loss and demyelination from chronic lesions in multiple sclerosis correlate with the clinical subgroup? J NEUROL NEUROSUR PS , 67 (6) 710 - 715.

Davies, GR; Altmann, DR; Hadjiprocopis, A; Rashid, W; Chard, DT; Griffin, CM; ... Miller, DH; + view all (2005) Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. J NEUROL , 252 (9) 1037 - 1044. 10.1007/s00415-005-0808-x.

Davies, GR; Altmann, DR; Rashid, W; Chard, DT; Griffin, CM; Barker, GJ; ... Miller, DH; + view all (2005) Emergence of thalamic magnetization transfer ratio abnormality in early relapsing-remitting multiple sclerosis. MULT SCLER , 11 (3) 276 - 281. 10.1191/1352458505ms1166oa.

Davies, GR; Chard, DT; Griffin, CMB; Rashid, W; Thompson, AJ; Miller, DH; (2002) Triple dose gadolinium enhanced MRI of the brain and spinal cord in early relapsing remitting multiple sclerosis is predictive of future relapses. J NEUROL NEUROSUR PS , 73 (2) 226 - 226.

Davies, GR; Hadjiprocopis, A; Altmann, DR; Chard, DT; Griffin, CM; Rashid, W; ... Miller, DH; + view all (2007) Normal-appearing grey and white matter T-1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study. MULT SCLER , 13 (2) 169 - 177. 10.1177/1352458506070726.

Davies, GR; Ramani, A; Dalton, CM; Tozer, DJ; Wheeler-Kingshott, CAM; Barker, GJ; ... Tofts, PS; + view all (2003) Preliminary magnetic resonance study of the macromolecular proton fraction in white matter: a potential marker of myelin? MULT SCLER , 9 (3) 246 - 249. 10.1191/1352458503ms911oa.

Davies, GR; Ramio-Torrenta, L; Hadjiprocopis, A; Chard, DT; Griffin, CMB; Rashid, W; ... Miller, DH; + view all (2004) Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis. J NEUROL NEUROSUR PS , 75 (7) 998 - 1002. 10.1136/jnnp.2003.021915.

Davies, GR; Tozer, DJ; Cercignani, M; Ramani, A; Dalton, CM; Thompson, AJ; ... Miller, DH; + view all (2004) Estimation of the macromolecular proton fraction and bound pool T-2 in multiple sclerosis. MULT SCLER , 10 (6) 607 - 613. 10.1191/1352458504ms1105oa.

De Stefano, N; Giorgio, A; Battaglini, M; Rovaris, M; Sormani, MP; Barkhof, F; ... Filippi, M; + view all (2010) Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. NEUROLOGY , 74 (23) 1868 - 1876. 10.1212/WNL.0b013e3181e24136.

Dehmeshki, J; Chard, DT; Leary, SM; Watt, HC; Silver, NC; Tofts, PS; ... Miller, DH; + view all (2003) The normal appearing grey matter in primary progressive multiple sclerosis - A magnetisation transfer imaging study. J NEUROL , 250 (1) 67 - 74. 10.1007/s00415-003-0955-x.

Dehmeshki, J; Silver, NC; Leary, SM; Tofts, PS; Thompson, AJ; Miller, DH; (2001) Magnetisation transfer ratio histogram analysis of primary progressive and other multiple sclerosis subgroups. J NEUROL SCI , 185 (1) 11 - 17.

Di Filippo, M; Anderson, VM; Altmann, DR; Swanton, JK; Plant, GT; Thompson, AJ; Miller, DH; (2010) Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes. J NEUROL NEUROSUR PS , 81 (2) 204 - 208. 10.1136/jnnp.2009.171769.

Dobson, R; Miller, RF; Palmer, HE; Feldmann, M; Thompson, EJ; Thompson, AJ; ... Giovannoni, G; + view all (2010) Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis. J NEUROIMMUNOL , 220 (1-2) 99 - 103. 10.1016/j.jneuroim.2010.01.012.

Dubois, B; Leary, SM; Nelissen, I; Opdenakker, G; Giovannoni, G; Thompson, AJ; (2003) Serum gelatinase B/MMP-9 in primary progressive multiple sclerosis patients treated with interferon-beta 1a. J NEUROL , 250 (9) 1037 - 1043. 10.1007/s00415-003-0110-8.

Dubois, B.D.; Keenan, E.; Porter, B.E,; Kapoor, R.; Rudge, P.; Thompson, A.J.; ... Giovannoni, G.; + view all (2003) Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre. Journal of Neurology Neurosurgery & Psychiatry , 74 (7) pp. 946-949. 10.1136/jnnp.74.7.946. Green open access
file

Dubois, BD; Keenan, E; Porter, BE; Kapoor, R; Rudge, P; Thompson, AJ; ... Giovannoni, G; + view all (2003) Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre. J NEUROL NEUROSUR PS , 74 (7) 946 - 949.

Edwards, SGM; Playford, ED; Hobart, JC; Thompson, AJ; (2002) Comparison of physician outcome measures and patients' perception of benefits of inpatient neurorehabilitation. BRIT MED J , 324 (7352) 1493 - 1493. Green open access
file

Edwards, SGM; Thompson, AJ; Losseff, N; Playford, ED; (2002) Shortening inpatient stay for stroke. LANCET , 359 (9324) 2205 - 2205.

Edwards, SGM; Thompson, AJ; Playford, ED; (2004) Integrated care pathways: disease-specific or process-specific? CLIN MED , 4 (2) 132 - 135.

Eshaghi, A; Bodini, B; Ridgway, GR; García-Lorenzo, D; Tozer, D; Sahraian, MA; ... Ciccarelli, O; + view all (2013) Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis. Neuroimage 10.1016/j.neuroimage.2013.09.059.

Farrell, R; Kapoor, R; Leary, S; Rudge, P; Thompson, AJ; Millerand, DH; Giovannoni, G; (2008) Neutralizing anti-interferon beta antibodies are associated with reduced side effects and delayed impact on efficacy of Interferon-beta. MULT SCLER , 14 (2) 212 - 218. 10.1177/1352458507082066.

Fazekas, F; Thompson, A; (2009) New MRI techniques and "aggressive" multiple sclerosis. MULT SCLER , 15 (3) 283 - 284. 10.1177/1352458509102997.

FEINSTEIN, A; RON, M; THOMPSON, A; (1993) A SERIAL STUDY OF PSYCHOMETRIC AND MAGNETIC-RESONANCE-IMAGING CHANGES IN MULTIPLE-SCLEROSIS. BRAIN , 116 569 - 602.

Fernando, KTM; McLean, MA; Chard, DT; MacManus, DG; Dalton, CM; Miszkiel, KA; ... Miller, DH; + view all (2004) Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. BRAIN , 127 1361 - 1369. 10.1093/brain/awh153.

Fernando, KTM; Tozer, DJ; Miszkiel, KA; Gordon, RM; Swanton, JK; Dalton, CM; ... Miller, DH; + view all (2005) Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. BRAIN , 128 2911 - 2925. 10.1093/brain/awh654.

FILIPPI, M; BARKER, GJ; HORSFIELD, MA; SACARES, PR; MACMANUS, DG; THOMPSON, AJ; ... MILLER, DH; + view all (1994) BENIGN AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS - A PRELIMINARY QUANTITATIVE MRI STUDY. J NEUROL , 241 (4) 246 - 251.

Filippi, M; Barker, GJ; Sacares, RP; Thompson, A; McDonald, I; Miller, D; (1993) Longstanding lesions and normal appearing white matter in benign and secondary progressive MS: a quantitative MRI study. Schweizer Archiv für Neurologie und Psychiatrie , 114 330 - 331. Gold open access

Filippi, M; Horsfield, MA; Tofts, PS; Barkhof, F; Thompson, AJ; Miller, DH; (1995) Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. BRAIN , 118 1601 - 1612.

FILIPPI, M; PATY, DW; KAPPOS, L; BARKHOF, F; COMPSTON, DAS; THOMPSON, AJ; ... MILLER, DH; + view all (1995) CORRELATIONS BETWEEN CHANGES IN DISABILITY AND T-2-WEIGHTED BRAIN MRI ACTIVITY IN MULTIPLE-SCLEROSIS - A FOLLOW-UP-STUDY. NEUROLOGY , 45 (2) 255 - 260.

Filippi, M; Watts, P; Eaton, L; Honer, J; McDonald, WI; Thompson, AJ; (1996) Mark VII Microclimate System (cooling suit) in the symptomatic treatment of multiple sclerosis patients with marked temperature sensitivity. Argomenti di Neurologia , 5 162 - 165.

Fisniku, LK; Altmann, DR; Cercignani, M; Tozer, DJ; Chard, DT; Jackson, JS; ... Miller, DH; + view all (2009) Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis. MULT SCLER , 15 (6) 668 - 677. 10.1177/1352458509103715. Gold open access

Fisniku, LK; Brex, PA; Altmann, DR; Miszkiel, KA; Benton, CE; Lanyon, R; ... Miller, DH; + view all (2008) Disability and T-2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. BRAIN , 131 808 - 817. 10.1093/brain/awm329.

Fisniku, LK; Chard, DT; Jackson, JS; Anderson, VM; Altmann, DR; Miszkiel, KA; ... Miller, DH; + view all (2008) Gray matter atrophy is related to long-term disability in multiple sclerosis. ANN NEUROL , 64 (3) 247 - 254. 10.1002/ana.21423.

Flachenecker, P; Khil, L; Bergmann, S; Kowalewski, M; Pascu, I; Perez-Miralles, F; ... Zwingers, T; + view all (2010) Development and pilot phase of a European MS register. J NEUROL , 257 (10) 1620 - 1627. 10.1007/s00415-010-5578-4.

Foong, J; Rozewicz, L; Chong, WK; Thompson, AJ; Miller, DH; Ron, MA; (2000) A comparison of neuropsychological deficits in primary and secondary progressive multiple sclerosis. J NEUROL , 247 (2) 97 - 101.

Foong, J; Rozewicz, L; Davie, CA; Thompson, AJ; Miller, DH; Ron, MA; (1999) Correlates of executive function in multiple sclerosis: The use of magnetic resonance spectroscopy as an index of focal pathology. J NEUROPSYCH CLIN N , 11 (1) 45 - 50.

Foong, J; Rozewicz, L; Quaghebeur, G; Davie, CA; Kartsounis, LD; Thompson, AJ; ... Ron, MA; + view all (1997) Executive function in multiple sclerosis - The role of frontal lobe pathology. BRAIN , 120 15 - 26.

Foong, J; Rozewicz, L; Quaghebeur, G; Thompson, AJ; Miller, DH; Ron, MA; (1998) Neuropsychological deficits in multiple sclerosis after acute relapse. J NEUROL NEUROSUR PS , 64 (4) 529 - 532.

Fox, NC; Jenkins, R; Leary, SM; Stevenson, VL; Losseff, NA; Crum, WR; ... Thompson, AJ; + view all (2000) Progressive cerebral atrophy in MS - A serial study using registered, volumetric MRI. NEUROLOGY , 54 (4) 807 - 812.

Fox, RJ; Thompson, A; Baker, D; Baneke, P; Brown, D; Browne, P; ... Zuidwijk, K; + view all (2012) Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS. Mult Scler , 18 (11) 1534 - 1540. 10.1177/1352458512458169.

FRANCIS, DA; THOMPSON, AJ; BROOKES, P; DAVEY, N; LECHLER, RI; MCDONALD, WI; BATCHELOR, JR; (1991) MULTIPLE-SCLEROSIS AND HLA - IS THE SUSCEPTIBILITY GENE REALLY HLA-DR OR -DQ. HUM IMMUNOL , 32 (2) 119 - 124.

Freeman, J; Hobart, JC; Langdon, DW; Thompson, AJ; (2000) Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis. J NEUROL NEUROSUR PS , 68 (2) 150 - 156.

Freeman, JA; Hobart, JC; Playford, ED; Undy, B; Thompson, AJ; (2005) Evaluating neurorehabilitation: lessons from routine data collection. J NEUROL NEUROSUR PS , 76 (5) 723 - 728. 10.1136/jnnp.2004.035956.

Freeman, JA; Hobart, JC; Thompson, AJ; (2001) Does adding MS-specific items to a generic measure (the SF-36) improve measurement? NEUROLOGY , 57 (1) 68 - 74.

Freeman, JA; Hobart, JC; Thompson, AJ; (1996) Outcomes-based research in neurorehabilitation: The need for multidisciplinary team involvement. DISABIL REHABIL , 18 (2) 106 - 110.

Freeman, JA; Hobart, JC; Thompson, AJ; (1995) Outcomes-based research in neurorehabilitation: the need for multidisciplinary team involvement. Disability and Rehabilitation , 17 323 - 327.

Freeman, JA; Langdon, DW; Hobart, JC; Thompson, AJ; (1999) Inpatient rehabilitation in multiple sclerosis - Do the benefits carry over into the community? NEUROLOGY , 52 (1) 50 - 56.

Freeman, JA; Langdon, DW; Hobart, JC; Thompson, AJ; (1997) The impact of inpatient rehabilitation on progressive multiple sclerosis. ANN NEUROL , 42 (2) 236 - 244.

Freeman, JA; Langdon, DW; Hobart, JC; Thompson, AJ; (1996) Health-related quality of life in people with multiple sclerosis undergoing inpatient rehabilitation. J NEUROL REHABIL , 10 (3) 185 - 194.

Freeman, JA; Playford, ED; Nicholas, RS; Thompson, AJ; (1996) A neurological rehabilitation unit: Audit of activity and outcome. J ROY COLL PHYS LOND , 30 (1) 21 - 26.

Freeman, JA; Thompson, AJ; (2000) Community services in multiple sclerosis: still a matter of chance. J NEUROL NEUROSUR PS , 69 (6) 728 - 732.

Freeman, JA; Thompson, AJ; (1998) Inpatient rehabilitation in MS. International MS Journal , 5 (1) 16 - 23.

Freeman, JA; Thompson, AJ; Fitzpatrick, R; Hutchinson, M; Miltenburger, C; Beckmann, K; ... European Study Grp Interferon-Beta1b,; + view all (2001) Interferon-beta 1b in the treatment of secondary progressive MS - Impact on quality of life. NEUROLOGY , 57 (10) 1870 - 1875.

Freeman, JA; Thompson, AJ; Freeman, JA; (2001) Building an evidence base for multiple sclerosis management: support for physiotherapy. J NEUROL NEUROSUR PS , 70 (2) 147 - 148.

Freund, P; Curt, A; Friston, K; Thompson, A; (2013) Tracking changes following spinal cord injury: insights from neuroimaging. Neuroscientist , 19 (2) 116 - 128. 10.1177/1073858412449192.

Freund, P; Rothwell, J; Craggs, M; Thompson, AJ; Bestmann, S; (2011) Corticomotor representation to a human forearm muscle changes following cervical spinal cord injury. Eur J Neurosci , 34 (11) 1839 - 1846. 10.1111/j.1460-9568.2011.07895.x.

Freund, P; Schneider, T; Nagy, Z; Hutton, C; Weiskopf, N; Friston, K; ... Thompson, AJ; + view all (2012) Degeneration of the injured cervical cord is associated with remote changes in corticospinal tract integrity and upper limb impairment. PLOS One , 7 (12) , Article e51729. 10.1371/journal.pone.0051729. Green and gold open access
file

Freund, P; Weiskopf, N; Ashburner, J; Wolf, K; Sutter, R; Altmann, DR; ... Curt, A; + view all (2013) MRI investigation of the sensorimotor cortex and the corticospinal tract after acute spinal cord injury: a prospective longitudinal study. Lancet Neurol 10.1016/S1474-4422(13)70146-7.

Freund, P; Weiskopf, N; Ward, NS; Hutton, C; Gall, A; Ciccarelli, O; ... Thompson, AJ; + view all (2011) Disability, atrophy and cortical reorganization following spinal cord injury. Brain , 134 (6) 1610 - 1622. 10.1093/brain/awr093. Green and gold open access
file

Freund, P; Wheeler-Kingshott, C; Jackson, J; Miller, D; Thompson, A; Ciccarelli, O; (2010) Recovery after spinal cord relapse in multiple sclerosis is predicted by radial diffusivity. MULT SCLER , 16 (10) 1193 - 1202. 10.1177/1352458510376180.

Freund, P; Wheeler-Kingshott, CA; Nagy, Z; Gorgoraptis, N; Weiskopf, N; Friston, K; ... Hutton, C; + view all (2012) Axonal integrity predicts cortical reorganisation following cervical injury. Journal of Neurology, Neurosurgery & Psychiatry , 83 (6) 629 -637. 10.1136/jnnp-2011-301875. Green and gold open access
file

Freund, P; Wheeler-Kingshott, CA; Nagy, Z; Gorgoraptis, N; Weiskopf, N; Friston, K; ... Hutton, C; + view all (2012) Axonal integrity predicts cortical reorganisation following cervical injury. J Neurol Neurosurg Psychiatry , 83 (6) 629 - 637. 10.1136/jnnp-2011-301875. Gold open access

Freund, PAB; Dalton, C; Wheeler-Kingshott, CAM; Glensman, J; Bradbury, D; Thompson, AJ; Weiskopf, N; (2010) Method for Simultaneous Voxel-Based Morphometry of the Brain and Cervical Spinal Cord Area Measurements Using 3D-MDEFT. J MAGN RESON IMAGING , 32 (5) 1242 - 1247. 10.1002/jmri.22340.

Garrard, P; Bradshaw, D; Jager, HR; Thompson, AJ; Losseff, N; Playford, D; (2002) Cognitive dysfunction after isolated brain stem insult. An underdiagnosed cause of long term morbidity. J NEUROL NEUROSUR PS , 73 (2) 191 - 194.

Garrard, P; Farnham, C; Thompson, AJ; Playford, ED; (2004) Rehabilitation of the cancer patient: Experience in a neurological unit. NEUROREHAB NEURAL RE , 18 (2) 76 - 79. 10.1177/0888439004266306.

Garrard, P; Farnham, C; Thompson, AJ; Playford, ED; (2004) Rehabilitation of the cancer patient: experience in a neurological unit. Neurorehabilitation and Neural Repair , 18 (2) pp.76 - 79.

Gasperini, C; Horsfield, MA; Thorpe, JW; Kidd, D; Barker, GJ; Tofts, PS; ... McDonald, WI; + view all (1996) Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: Relationship to clinical parameters. J MAGN RESON IMAGING , 6 (4) 580 - 584.

Gasperini, C; Pozzilli, C; Bastianello, S; Koudriavtseva, T; Colleluori, A; Millefiorini, E; ... Fieschi, C; + view all (1997) The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: A longitudinal MRI study in relapsing-remitting multiple sclerosis patients. ACTA NEUROL SCAND , 95 (4) 201 - 207.

GASS, A; BARKER, GJ; KIDD, D; THORPE, JW; MACMANUS, D; BRENNAN, A; ... MILLER, DH; + view all (1994) CORRELATION OF MAGNETIZATION-TRANSFER RATIO WITH CLINICAL DISABILITY IN MULTIPLE-SCLEROSIS. ANN NEUROL , 36 (1) 62 - 67.

Gawne-Cain, ML; O'Riordan, JI; Coles, A; Newell, B; Thompson, AJ; Miller, DH; (1998) MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences. J NEUROL NEUROSUR PS , 64 (2) 197 - 203.

GawneCain, ML; ORiordan, JI; Thompson, AJ; Moseley, IF; Miller, DH; (1997) Multiple sclerosis lesion detect in the brain: A comparison of fast fluid-attenuated inversion recovery and conventional T2-weighted dual spin echo. NEUROLOGY , 49 (2) 364 - 370.

Giovannoni, G; (2003) Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b. NEUROLOGY , 61 (7) 1025 - 1025.

Giovannoni, G; Lai, M; Kidd, D; Thorpe, JW; Miller, DH; Thompson, AJ; ... Thompson, EJ; + view all (1997) Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis. BRAIN , 120 1 - 13.

Giovannoni, G; Lai, M; Thorpe, J; Kidd, D; Chamoun, V; Thompson, AJ; ... Thompson, EJ; + view all (1997) Longitudinal study of soluble adhesion molecules in multiple sclerosis: Correlation with gadolinium enhanced magnetic resonance Imaging. NEUROLOGY , 48 (6) 1557 - 1565.

Giovannoni, G; Miller, DH; Losseff, NA; Sailer, M; Lewellyn-Smith, N; Thompson, AJ; Thompson, EJ; (2001) Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis. J NEUROL , 248 (6) 487 - 495.

Giovannoni, G; Thompson, AJ; Miller, DH; Thompson, EJ; (2001) Fatigue is not associated with raised inflammatory markers in multiple sclerosis. NEUROLOGY , 57 (4) 676 - 681.

Giovannoni, G; Thorpe, JW; Kidd, D; Kendall, BE; Moseley, IF; Thompson, AJ; ... Thompson, EJ; + view all (1996) Soluble E-selectin in multiple sclerosis: Raised concentrations in patients with primary progressive disease. J NEUROL NEUROSUR PS , 60 (1) 20 - 26.

Gorgoraptis, N; Wheeler-Kingshott, CAM; Jenkins, TM; Altmann, DR; Miller, DH; Thompson, AJ; Ciccarelli, O; (2010) Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis. MULT SCLER , 16 (5) 555 - 565. 10.1177/1352458510362440.

Griffin, CM; Chard, DT; Ciccarelli, O; Kapoor, R; Barker, GJ; Thompson, AJ; Miller, DH; (2001) Diffusion tensor imaging in early relapsing-remitting multiple sclerosis. MULT SCLER , 7 (5) 290 - 297.

Griffin, CM; Chard, DT; Parker, GJM; Barker, GJ; Thompson, AJ; Miller, DH; (2002) The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis. J NEUROL , 249 (2) 193 - 199.

Griffin, CM; Dehmeshki, J; Chard, DT; Parker, GJM; Barker, GJ; Thompson, AJ; Miller, DH; (2002) T1 histograms of normal-appearing brain tissue are abnormal in early relapsing-remitting multiple sclerosis. MULT SCLER , 8 (3) 211 - 216. 10.1191/1352458502ms807oa.

Griffin, CM; Parker, GJM; Barker, GJ; Tompson, AJ; Miller, DH; (2000) MTR and TI provide complementary information in MS NAWM, but not in lesions. MULT SCLER , 6 (5) 327 - 331.

Grimaud, J; Barker, GJ; Wang, L; Lai, M; MacManus, DG; Webb, SL; ... Miller, DH; + view all (1999) Correlation of magnetic resonance imaging parameters with clinical disability in multiple sclerosis: a preliminary study. J NEUROL , 246 (10) 961 - 967.

Hardy, J; Thompson, AJ; (2011) Dissecting the Familial Risk of Multiple Sclerosis. ANN NEUROL , 69 (1) 11 - 12. 10.1002/ana.22353.

Hatch, J; Johnson, J; Thompson, A; (1998) Standards of health care for people with multiple sclerosis. MS Management , 5 (1) 16 - 23.

Hickman, SJ; Coulon, O; Parker, GJM; Barker, GJ; Stevenson, VL; Chard, DT; ... Miller, DH; + view all (2003) Application of a B-spline active surface technique to the measurement of cervical cord volume in multiple sclerosis from three-dimensional MR images. JOURNAL OF MAGNETIC RESONANCE IMAGING , 18 (3) 368 - 371. 10.1002/jmri.10354.

Hickman, SJ; Toosy, AT; Jones, SJ; Altmann, DR; Miszkiel, KA; MacManus, DG; ... Miller, DH; + view all (2004) A serial MRI study following optic nerve mean area in acute optic neuritis. BRAIN , 127 2498 - 2505. 10.1093/brain/awh284.

Hickman, SJ; Toosy, AT; Jones, SJ; Altmann, DR; Miszkiel, KA; MacManus, DG; ... Miller, DH; + view all (2004) Serial magnetization transfer imaging in acute optic neuritis. BRAIN , 127 692 - 700. 10.1093/brain/awh076.

Hickman, SJ; Toosy, AT; Miszkiel, KA; Jones, SJ; Altmann, DR; MacManus, DG; ... Miller, DH; + view all (2004) Visual recovery following acute optic neuritis - A clinical, electrophysiological and magnetic resonance imaging study. J NEUROL , 251 (8) 996 - 1005. 10.1007/s00415-004-0477-1.

Hobart, J; Freeman, J; Lamping, D; Fitzpatrick, R; Thompson, A; (2001) The SF-36 in multiple sclerosis: why basic assumptions must be tested. J NEUROL NEUROSUR PS , 71 (3) 363 - 370.

Hobart, J; Freeman, J; Thompson, A; (2000) Kurtzke scales revisited: the application of psychometric methods to clinical intuition. BRAIN , 123 1027 - 1040.

Hobart, J; Kalkers, N; Barkhof, F; Uitdehaag, B; Polman, C; Thompson, A; (2004) Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite. MULT SCLER , 10 (1) 41 - 46. 10.1191/1352458504ms983oa.

Hobart, J; Lamping, D; Fitzpatrick, R; Riazi, A; Thompson, A; (2001) The Multiple Sclerosis Impact Scale (MSIS-29) - A new patient-based outcome measure. BRAIN , 124 962 - 973.

Hobart, J; Riazi, A; Lamping, D; Fitzpatrick, R; Thompson, AJ; (2002) Evaluating the use of B-INTERFERON in the UK: From whose perspective? J NEUROL NEUROSUR PS , 73 (2) 227 - 227.

Hobart, J; Thompson, A; (1997) A comparison of two neurologic scoring instruments for multiple sclerosis. J NEUROL , 244 (1) 60 - 60.

Hobart, J.; Lamping, D.; Fitzpatrick, R.; Riazi, A.; Thompson, A.; (2001) The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain , 124 (5) pp. 962-973. 10.1093/brain/124.5.962.

Hobart, J.C.; Lamping, D.L.; Freeman, J.A.; Langdon, D.W.; McLellan, D.L.; Greenwood, R.J.; Thompson, A.J.; (2001) Evidence-based measurement: which disability scale for neurologic rehabilitation? Neurology , 57 (4) pp. 639-644.

Hobart, JC; Cano, SJ; Thompson, AJ; (2010) Effect sizes can be misleading: is it time to change the way we measure change? J NEUROL NEUROSUR PS , 81 (9) 1044 - 1048. 10.1136/jnnp.2009.201392.

Hobart, JC; Cano, SJ; Zajicek, JP; Thompson, AJ; (2007) Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. LANCET NEUROL , 6 (12) 1094 - 1105.

Hobart, JC; Lamping, DL; Freeman, JA; Langdon, DW; McLellan, DL; Greenwood, RJ; Thompson, AJ; (2001) Evidence-based measurement - Which disability scale for neurologic rehabilitation? NEUROLOGY , 57 (4) 639 - 644.

Hobart, JC; Lamping, DL; Thompson, AJ; (1996) Evaluating neurological outcome measures: The bare essentials. J NEUROL NEUROSUR PS , 60 (2) 127 - 130.

Hobart, JC; Riazi, A; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2005) How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales. J NEUROL NEUROSUR PS , 76 (11) 1539 - 1543. 10.1136/jnnp.2005.064584.

Hobart, JC; Riazi, A; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2004) Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. HEALTH TECHNOL ASSES , 8 (9) 1 - +.

Hobart, JC; Riazi, A; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2004) Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess , 8 (9) iii - 48.

Hobart, JC; Riazi, A; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2003) Measuring the impact of MS on walking ability - The 12-Item MS Walking Scale (MSWS-12). NEUROLOGY , 60 (1) 31 - 36.

Hobart, JC; Riazi, A; Thompson, AJ; Styles, IM; Ingram, W; Vickery, PJ; ... Zajicek, JP; + view all (2006) Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88). BRAIN , 129 224 - 234. 10.1093/brain/awh675.

Holland, A; O'Connor, RJ; Thompson, AJ; Playford, ED; Hobart, JC; (2006) Talking the talk on walking the walk - A 12-item generic walking scale suitable for neurological conditions? J NEUROL , 253 (12) 1594 - 1602. 10.1007/s00415-006-0272-2.

Horsfield, MA; Barker, GJ; Barkhof, F; Miller, DH; Thompson, AJ; Filippi, M; (2003) Guidelines for using quantitative magnetization transfer magnetic resonance imaging for monitoring treatment of multiple sclerosis. J MAGN RESON IMAGING , 17 (4) 389 - 397. 10.1002/jmri.10266.

Hunter, RM; Davie, C; Rudd, A; Thompson, A; Walker, H; Thomson, N; ... Morris, S; + view all (2013) Impact on clinical and cost outcomes of a centralized approach to acute stroke care in london: a comparative effectiveness before and after model. PLoS One , 8 (8) e70420 - ?. 10.1371/journal.pone.0070420.

Ingle, GT; Sastre-Garriga, J; Miller, DH; Thompson, AJ; (2005) Is inflammation important in early PPMS? a longitudinal MRI study. J NEUROL NEUROSUR PS , 76 (9) 1255 - 1258. 10.1136/jnnp.2004.036590. Gold open access

Ingle, GT; Stevenson, VL; Leary, SM; Miller, DH; Thompson, AJ; (2002) A 5 year longitudinal MRI study of ventricular volume in primary progressive multiple sclerosis. J NEUROL NEUROSUR PS , 73 (2) 217 - 217.

Ingle, GT; Stevenson, VL; Miller, DH; Leary, SM; Rovaris, M; Barkhof, F; ... Thompson, AJ; + view all (2002) Two-year follow-up study of primary and transitional progressive multiple sclerosis. MULT SCLER , 8 (2) 108 - 114. 10.1191/1352458502ms778oa.

Ingle, GT; Stevenson, VL; Miller, DH; Thompson, AJ; (2003) Primary progressive multiple sclerosis: a 5-year clinical and MR study. BRAIN , 126 2528 - 2536. 10.1093/brain/awg261.

Ingle, GT; Thompson, AJ; Miller, DH; (2002) Magnetic resonance imaging in primary progressive multiple sclerosis. J REHABIL RES DEV , 39 (2) 261 - 271. Gold open access

Inglese, M; van Waesberghe, JHTM; Rovaris, M; Beckmann, K; Barkhof, F; Hahn, D; ... Filippi, M; + view all (2003) The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS. NEUROLOGY , 60 (5) 853 - 860.

Ingram, DAM; Thompson, AJ; Swash, M; (1988) Central motor conduction in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry , 51 487 - 494.

Isaacs, JD; Bodini, B; Ciccarelli, O; Scadding, GK; Thompson, AJ; (2011) Atopic myelitis in a European woman residing in Japan. J NEUROL NEUROSUR PS , 82 (9) 1022 - 1024. 10.1136/jnnp.2009.186775.

Jarrett, L; Leary, SM; Porter, B; Richardson, D; Rosso, T; Powell, M; Thompson, AJ; (2001) Managing spasticity in people with multiple sclerosis: a goal-oriented approach to intrathecal baclofen therapy. International Journal of MS Care , 3 (4)

Jarrett, L; Nandi, P; Thompson, AJ; (2002) Managing severe lower limb spasticity in multiple sclerosis: does intrathecal phenol have a role? J NEUROL NEUROSUR PS , 73 (6) 705 - 709.

Jenkins, T; Ciccarelli, O; Toosy, A; Miszkiel, K; Wheeler-Kingshott, C; Altmann, D; ... Thompson, A; + view all (2010) Dissecting Structure-Function Interactions in Acute Optic Neuritis to Investigate Neuroplasticity. HUM BRAIN MAPP , 31 (2) 276 - 286. 10.1002/hbm.20863.

Jenkins, T; Toosy, AT; Ciccarelli, O; Miszkiel, KA; Wheeler-Kingsnott, CA; Henderson, AP; ... Thompson, AJ; + view all (2010) Neuroplasticity Predicts Outcome of Optic Neuritis Independent of Tissue Damage Reply. ANN NEUROL , 68 (6) 971 - 971. 10.1002/ana.22030.

Jenkins, TM; Ciccarelli, O; Atzori, M; Wheeler-Kingshott, CAM; Miller, DH; Thompson, AJ; Toosy, AT; (2011) Early pericalcarine atrophy in acute optic neuritis is associated with conversion to multiple sclerosis. J NEUROL NEUROSUR PS , 82 (9) 1017 - 1021. 10.1136/jnnp.2010.239715.

Jenkins, TM; Khaleeli, Z; Thompson, AJ; (2008) Diagnosis and management of primary progressive multiple sclerosis. Minerva Med , 99 (2) 141 - 155.

Jenkins, TM; Thompson, AJ; (2009) Diagnosing and managing multiple sclerosis. Practitioner , 253 (1721) 25 - 3.

Jenkins, TM; Thompson, AJ; (2007) GPs have pivotal role in managing MS. Practitioner , 251 (1694) 37 - passim.

Jenkins, TM; Toosy, AT; Ciccarelli, O; Miszkiel, KA; Wheeler-Kingshott, CA; Henderson, AP; ... Thompson, AJ; + view all (2010) Neuroplasticity Predicts Outcome of Optic Neuritis Independent of Tissue Damage. ANN NEUROL , 67 (1) 99 - 113. 10.1002/ana.21823.

Johansen-Berg, H; Behrens, TEJ; Sillery, E; Ciccarelli, O; Thompson, AJ; Smith, SM; Matthews, PM; (2005) Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. CEREB CORTEX , 15 (1) 31 - 39. 10.1093/cercor/bhh105.

Johansen-Berg, H.; Behrens, T.E.J.; Ciccarelli, O.; Thompson, A.J.; Smith, S.M.; Matthews, P.M.; Sillery, E.; (2005) Functional-anatomical validation and individual variation of diffusion tractography-based segmentation of the human thalamus. Cerebral Cortex , 15 (1) pp. 31-39. 10.1093/cercor/bhh105.

Johnson, J; Thompson, A; (1996) Rehabilitation in a neuroscience centre: the role of expert assessment and selection. British Journal of Therapy and Rehabilitation , 3 303 - 308.

Jones, SJ; Turano, G; Kriss, A; Shawkat, F; Kellar-Wood, HF; Thompson, AJ; (1995) Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and intelligence quotient. Journal of Neurology, Neurosurgery and Psychiatry , 59 260 - 265.

JONES, SJ; TURANO, G; KRISS, A; SHAWKAT, F; KENDALL, B; THOMPSON, AJ; (1995) VISUAL-EVOKED POTENTIALS IN PHENYLKETONURIA - ASSOCIATION WITH BRAIN MRI, DIETARY STATE, AND IQ. J NEUROL NEUROSUR PS , 59 (3) 260 - 265.

Kachramanoglou, C; De Vita, E; Thomas, DL; Wheeler-Kingshott, CA; Balteau, E; Carlstedt, T; ... Ciccarelli, O; + view all (2013) Metabolic changes in the spinal cord after brachial plexus root re-implantation. Neurorehabil Neural Repair , 27 (2) 118 - 124. 10.1177/1545968312457825.

Kachramanoglou, C; De Vita, E; Thomas, DL; Wheeler-Kingshott, CAM; Balteau, E; Carlstedt, T; ... Ciccarelli, O; + view all (2013) Metabolic Changes in the Spinal Cord After Brachial Plexus Root Re-implantation. NEUROREHABILITATION AND NEURAL REPAIR , 27 (2) 118 - 124. 10.1177/1545968312457825.

Kapeller, P; Brex, PA; Chard, D; Dalton, C; Griffin, CM; McLean, MA; ... Miller, DH; + view all (2002) Quantitative H-1 MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. MULT SCLER , 8 (3) 207 - 210. 10.1191/1352458502ms822oa.

Kapeller, P; McLean, MA; Griffin, CM; Chard, D; Parker, GJM; Barker, GJ; ... Miller, DH; + view all (2001) Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J NEUROL , 248 (2) 131 - 138.

Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Beckmann, K; Dahlke, F; European Study Grp Beta-1b Seconda,; (2001) Final analysis of the European multicenter trial on IFN beta-1b in secondary-progressive MS. NEUROLOGY , 57 (11) 1969 - 1975.

Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Dahlke, F; Knight, R; ... Eur Study Grp Interferon Beta-1b Sec,; + view all (1998) Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. LANCET , 352 (9139) 1491 - 1497.

Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Dahlke, F; Knight, R; ... Toyka, K; + view all (1998) Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. The Lancet , 352 (9139) 1491 - 1497.

Kappos, L; Polman, C; Thompson, AJ; Duda, P; Clanet, M; Comi, G; ... Montalban, X; + view all (2003) Towards a European Network for Multiple Sclerosis Trials (ENMST). MULT SCLER , 9 (6) 627 - 629. 10.1191/1352458503ms962xx.

Kappos, L; Weinshenker, B; Pozzilli, C; Thompson, AJ; Dahlke, F; Beckmann, K; ... McFarland, H; + view all (2004) Interferon beta-1b in secondary progressive MS: A combined analysis of the two trials. Neurology , 63 (10) 1779 - 1787.

Karrenbauer, VD; Leoni, V; Lim, ET; Giovannoni, G; Ingle, GT; Sastre-Garriga, J; ... Masterman, T; + view all (2006) Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. CLIN NEUROL NEUROSUR , 108 (5) 456 - 460. 10.1016/j.clineuro.2005.07.010.

KERMODE, AG; RUDGE, P; THOMPSON, AJ; DUBOULAY, EPGH; MCDONALD, WI; (1990) MRI OF THORACIC CORD IN TROPICAL SPASTIC PARAPARESIS. J NEUROL NEUROSUR PS , 53 (12) 1110 - 1111.

KERMODE, AG; RUDGE, P; THOMPSON, AJ; DUBOULAY, EPGH; MCDONALD, WI; (1990) MRI OF THORACIC CORD IN TROPICAL SPASTIC PARAPARESIS. J NEUROL NEUROSUR PS , 53 (8) 710 - 710.

KERMODE, AG; THOMPSON, AJ; TOFTS, P; MACMANUS, DG; KENDALL, BE; KINGSLEY, DPE; ... MCDONALD, WI; + view all (1990) BREAKDOWN OF THE BLOOD-BRAIN-BARRIER PRECEDES SYMPTOMS AND OTHER MRI SIGNS OF NEW LESIONS IN MULTIPLE-SCLEROSIS - PATHOGENETIC AND CLINICAL IMPLICATIONS. BRAIN , 113 1477 - 1489.

KERMODE, AG; TOFTS, PS; THOMPSON, AJ; MACMANUS, DG; RUDGE, P; KENDALL, BE; ... MCDONALD, WI; + view all (1990) HETEROGENEITY OF BLOOD-BRAIN-BARRIER CHANGES IN MULTIPLE-SCLEROSIS - AN MRI STUDY WITH GADOLINIUM-DTPA ENHANCEMENT. NEUROLOGY , 40 (2) 229 - 235.

Kerrison, S; Laws, S; Cane, M; Thompson, A; (2008) The patient's experience of being a human subject. J ROY SOC MED , 101 (8) 416 - 422. 10.1258/jrsm.2007.070288.

Kersten, P; McLellan, DL; Gross-Paju, K; Grigoriadis, N; Bencivenga, R; Beneton, C; ... Thompson, AJ; + view all (2000) A questionnaire assessment of unmet needs for rehabilitation services and resources for people with multiple sclerosis: results of a pilot survey in five European countries. CLIN REHABIL , 14 (1) 42 - 49.

Kesselring, J; Coenen, M; Cieza, A; Thompson, A; Kostanjsek, N; Stucki, G; (2008) Developing the ICF Core Sets for multiple sclerosis to specify functioning. MULT SCLER , 14 (2) 252 - 254. 10.1177/1352458507082615.

Kesselring, J; Thompson, AJ; (1997) Spasticity, ataxia and fatigue in multiple sclerosis. BAILLIERE CLIN NEUR , 6 (3) 429 - 445.

Khaleeli, Z; Altmann, DR; Cercignani, M; Ciccarelli, O; Miller, DH; Thompson, AJ; (2008) Magnetization Transfer Ratio in Gray Matter A Potential Surrogate Marker for Progression in Early Primary Progressive Multiple Sclerosis. ARCH NEUROL-CHICAGO , 65 (11) 1454 - 1459.

Khaleeli, Z; Cereignani, M; Audoin, B; Ciccarelli, O; Miller, DH; Thompson, AJ; (2007) Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. NEUROIMAGE , 37 (1) 253 - 261. 10.1016/j.neuroimage.2007.04.056.

Khaleeli, Z; Ciccarelli, O; Manfredonia, F; Barkhof, F; Brochet, B; Cercignani, M; ... Thompson, A; + view all (2008) Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study. ANN NEUROL , 63 (6) 790 - 793. 10.1002/ana.21375.

Khaleeli, Z; Ciccarelli, O; Mizskiel, K; Altmann, D; Miller, DH; Thompson, AJ; (2010) Lesion enhancement diminishes with time in primary progressive multiple sclerosis. MULT SCLER , 16 (3) 317 - 324. 10.1177/1352458509358090.

Khaleeli, Z; Sastre-Garriga, J; Ciccarelli, O; Miller, DH; Thompson, AJ; (2007) Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis. J NEUROL NEUROSUR PS , 78 (10) 1076 - 1082. 10.1136/jnnp.2006.107565. Gold open access

Kidd, D; Barker, GJ; Tofts, PS; Gass, A; Thompson, AJ; McDonald, WI; Miller, DH; (1997) The transverse magnetisation decay characteristics of longstanding lesions and normal-appearing white matter in multiple sclerosis. J NEUROL , 244 (2) 125 - 130.

Kidd, D; Howard, RS; Losseff, NA; Thompson, AJ; (1995) The benefit of inpatient neurorehabilitation in multiple sclerosis. Clinical Rehabilitation , 9 (3) 198 - 203.

KIDD, D; STEWART, G; BALDRY, J; JOHNSON, J; ROSSITER, D; PETRUCKEVITCH, A; THOMPSON, AJ; (1995) THE FUNCTIONAL INDEPENDENCE MEASURE - A COMPARATIVE VALIDITY AND RELIABILITY STUDY. DISABIL REHABIL , 17 (1) 10 - 14.

Kidd, D; Thompson, AJ; (1997) Prospective study of neurorehabilitation in multiple sclerosis. J NEUROL NEUROSUR PS , 62 (4) 423 - 424.

KIDD, D; THOMPSON, AJ; KENDALL, BE; MILLER, DH; MCDONALD, WI; (1994) BENIGN FORM OF MULTIPLE-SCLEROSIS - MRI EVIDENCE FOR LESS FREQUENT AND LESS INFLAMMATORY DISEASE-ACTIVITY. J NEUROL NEUROSUR PS , 57 (9) 1070 - 1072.

Kidd, D; Thompson, AJ; MacManus, DG; Kendall, BE; McDonald, WI; (1993) Benign MS:MRI evidence for a less inflammatory disease. Journal of Neurology, Neurosurgery and Psychiatry , 56 730 - ?.

Kidd, D; Thompson, PD; Day, BL; Rothwell, JC; Kendall, BE; Thompson, AJ; ... McDonald, WI; + view all (1998) Central motor conduction time in progressive multiple sclerosis - Correlations with MRI and disease activity. BRAIN , 121 1109 - 1116.

Kidd, D; Thorpe, JW; Kendall, BE; Barker, GJ; Miller, DH; McDonald, WI; Thompson, AJ; (1996) MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J NEUROL NEUROSUR PS , 60 (1) 15 - 19.

KIDD, D; THORPE, JW; THOMPSON, AJ; KENDALL, BE; MOSELEY, IF; MACMANUS, DG; ... MILLER, DH; + view all (1993) SPINAL-CORD MRI USING MULTIARRAY COILS AND FAST SPIN-ECHO .2. FINDINGS IN MULTIPLE-SCLEROSIS. NEUROLOGY , 43 (12) 2632 - 2637.

Kolappan, M; Henderson, APD; Jenkins, TM; Wheeler-Kingshott, CAM; Plant, GT; Thompson, AJ; Miller, DH; (2009) Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis. J NEUROL , 256 (3) 305 - 319. 10.1007/s00415-009-0123-z.

Koudriavtseva, T; Thompson, AJ; Fiorelli, M; Gasperini, C; Bastianello, S; Bozzao, A; ... Pozzilli, C; + view all (1997) Gadolinium enahnced MRI predicts clinical amd MRI disease activity in relapsing-remitting multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry , 62 285 - 287.

Kragt, JJ; Thompson, AJ; Montalban, X; Tintore, M; Rio, J; Polman, CH; Uitdehaag, BMJ; (2008) Responsiveness and predictive value of EDSS and MSFC in primary progressive MS. NEUROLOGY , 70 (13) 1084 - 1091.

Lai, HM; Davie, CA; Gass, A; Barker, GJ; Webb, S; Tofts, PS; ... Miller, DH; + view all (1997) Serial magnetisation transfer ratios in gadolinium-enhancing lesions in multiple sclerosis. J NEUROL , 244 (5) 308 - 311.

Lai, M; Hodgson, T; GawneCain, M; Webb, S; MacManus, D; McDonald, WI; ... Miller, DH; + view all (1996) A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J NEUROL NEUROSUR PS , 60 (3) 339 - 341.

Langdon, DW; Thompson, AJ; (2000) Relation of impairment to everyday competence in visual disorientation syndrome: Evidence from a single case study. ARCH PHYS MED REHAB , 81 (5) 686 - 691.

Langdon, DW; Thompson, AJ; (1999) Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome. MULT SCLER , 5 (2) 94 - 100.

Langdon, DW; Thompson, AJ; (1996) Cognitive problems in multiple sclerosis. MS Management , 3 1 - 9.

Lazeron, RHC; Langdon, DW; Filippi, M; van Waesberghe, JHTM; Stevenson, VL; Boringa, JBS; ... Barkhof, F; + view all (2000) Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR. MULT SCLER , 6 (4) 280 - 285.

Leary, SM; Brex, PA; MacManus, DG; Parker, GJM; Barker, GJ; Miller, DH; Thompson, AJ; (2000) A H-1 magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis. MAGN RESON IMAGING , 18 (4) 455 - 459.

Leary, SM; Davie, CA; Parker, GJM; Stevenson, VL; Wang, LQ; Barker, GJ; ... Thompson, AJ; + view all (1999) H-1 Magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis. J NEUROL , 246 (11) 1023 - 1026.

Leary, SM; Miller, DH; Stevenson, VL; Brex, PA; Chard, DT; Thompson, AJ; (2003) Interferon beta-1a in primary progressive MS - An exploratory, randomized, controlled trial. NEUROLOGY , 60 (1) 44 - 51.

Leary, SM; Parker, GJM; Stevenson, VL; Barker, GJ; Miller, DH; Thompson, AJ; (1999) Reproducibility of magnetic resonance imaging measurements of spinal cord atrophy: The role of quality assurance. MAGN RESON IMAGING , 17 (5) 773 - 776.

Leary, SM; Porter, B; Thompson, AJ; (2005) Multiple sclerosis: diagnosis and the management of acute relapses. POSTGRAD MED J , 81 (955) 302 - 308. 10.1136/pgmj.2004.029413.

Leary, SM; Silver, NC; Stevenson, VL; Barker, GJ; Miller, DH; Thompson, AJ; (1999) Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis. MULT SCLER , 5 (5) 313 - 316.

Leary, SM; Stevenson, VL; Miller, DH; Thompson, AJ; (1999) Problems in designing and recruiting to therapeutic trials in primary progressive multiple sclerosis. J NEUROL , 246 (7) 562 - 568.

Leary, SM; Thompson, AJ; (2005) Primary progressive multiple sclerosis - Current and future treatment options. CNS DRUGS , 19 (5) 369 - 376.

Leary, SM; Thompson, AJ; (2004) The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis. J NEUROL NEUROSUR PS , 75 (3) 508 - 509.

Leary, SM; Thompson, AJ; (2003) Interferon beta-1a in primary progressive multiple sclerosis. J NEUROL SCI , 206 (2) 215 - 216.

Leary, SM; Thompson, AJ; (2000) Current management of multiple sclerosis. INT J CLIN PRACT , 54 (3) 161 - 169.

Leslie, TA; Goldsmith, PC; Thompson, AJ; Dowd, PM; (1993) Degos disease and spastic paraplegia. Clinical and Experimental Dermatology , 18 344 - 346.

Lim, ET; Petzold, A; Leary, SM; Altmann, DR; Keir, G; Thompson, EJ; ... Giovannoni, G; + view all (2004) Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a. J Negat Results Biomed , 3 4 - ?. 10.1186/1477-5751-3-4.

Liu, C; Playford, ED; Thompson, AJ; (2003) Does neurorehabilitation have a role in relapsing-remitting multiple sclerosis? J NEUROL , 250 (10) 1214 - 1218. 10.1007/s00415-003-0187-0.

Liu, C; Thompson, AJ; Playford, ED; (2004) Patient dissatisfaction: Insights into the rehabilitation process. J NEUROL , 251 (9) 1094 - 1097. 10.1007/s00415-004-0488-y.

LlewellynSmith, N; Lai, M; Miller, DH; Rudge, P; Thompson, AJ; Cuzner, ML; (1997) Effects of anti-CD4 antibody treatment on lymphocyte subsets and stimulated tumor necrosis factor alpha production - A study of 29 multiple sclerosis patients entered into a clinical trial of cM-T412. NEUROLOGY , 48 (4) 810 - 816.

Losseff, NA; Kingsley, DP; McDonald, WI; Miller, DH; Thompson, AJ; (1996) Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis. Mult Scler , 1 (4) 218 - 222.

Losseff, NA; Miller, DH; Kidd, D; Thompson, AJ; (2001) The predictive value of gadolinium enhancement for long term disability in relapsing-remitting multiple sclerosis - preliminary results. MULT SCLER , 7 (1) 23 - 25.

Losseff, NA; Thompson, AJ; (1995) The medical management of increased tone. Physiotherapy , 81 480 - 484.

Losseff, NA; Wang, L; Lai, HM; Yoo, DS; GawneCain, ML; McDonald, WI; ... Thompson, AJ; + view all (1996) Progressive cerebral atrophy in multiple sclerosis - A serial MRI study. BRAIN , 119 2009 - 2019.

Losseff, NA; Wang, L; Miller, DH; Thompson, AJ; (2001) T1 hypointensity of the spinal cord in multiple sclerosis. J NEUROL , 248 (6) 517 - 521.

Losseff, NA; Webb, SL; ORiordan, JI; Page, R; Wang, L; Barker, GJ; ... Thompson, AJ; + view all (1996) Spinal cord atrophy and disability in multiple sclerosis - A new reproducible and sensitive MRI method with potential to monitor disease progression. BRAIN , 119 701 - 708.

Lublin, FD; Reingold, SC; Cohen, JA; Cutter, GR; Sørensen, PS; Thompson, AJ; ... Polman, CH; + view all (2014) Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology 10.1212/WNL.0000000000000560.

Lycklama, G; Thompson, A; Filippi, M; Miller, D; Polman, C; Fazekas, F; Barkhof, F; (2003) Spinal-cord MRI in multiple sclerosis. The Lancet Neurology , 2 (9) 555 - 562.

Mancini, L; Ciccarelli, O; Manfredonia, F; Thornton, JS; Agosta, F; Barkhof, F; ... Yousry, T; + view all (2009) Short-term adaptation to a simple motor task: A physiological process preserved in multiple sclerosis. NEUROIMAGE , 45 (2) 500 - 511. 10.1016/j.neuroimage.2008.12.006.

Manfredonia, F; Ciccarelli, O; Khaleeli, Z; Tozer, DJ; Sastre-Garriga, J; Miller, DH; Thompson, AJ; (2007) Normal-appearing brain T1 relaxation time predicts disability in early primary progressive multiple sclerosis. ARCH NEUROL-CHICAGO , 64 (3) 411 - 415.

Manji, H; Connolly, S; McAllister, RH; Valentine, AR; Kendall, BE; Fell, M; ... Weller, IV; + view all (1994) Serial MRI of the brain in asymptomatic patients infected with HIV: results from the UCMSM/Medical Research Council neurology cohort. Journal of Neurology, Neurosurgery and Psychiatry , 57 144 - 149.

Mann, CLA; Davies, MB; Stevenson, VL; Leary, SM; Boggild, MD; Ko, CK; ... Hawkins, CP; + view all (2002) Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J NEUROIMMUNOL , 129 (1-2) 197 - 204.

Manson, SC; Wegner, C; Filippi, M; Barkhof, F; Beckmann, C; Ciccarelli, O; ... Matthews, PM; + view all (2008) Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. EXP BRAIN RES , 187 (1) 25 - 31. 10.1007/s00221-008-1276-1.

Marsden, J; Ramdharry, G; Stevenson, V; Thompson, A; (2012) Muscle paresis and passive stiffness: key determinants in limiting function in Hereditary and Sporadic Spastic Paraparesis. Gait & Posture , 35 (2) 266 - 271. 10.1016/j.gaitpost.2011.09.018. Green and gold open access
file

MARTIN, EA; LAVIN, PJ; THOMPSON, AJ; (1984) PAINFUL EXTREMITIES AND NEUROLOGICAL DISORDER IN ESSENTIAL THROMBOCYTHEMIA. J ROY SOC MED , 77 (5) 372 - 374.

Martino, G; Franklin, RJM; Van Evercooren, AB; Kerr, DA; Stem Cells in MS Consensus Group,; (2010) Stem cell transplantation in multiple sclerosis: current status and future prospects. Nature Rev Neurol , 6 247 - 255.

McCrone, P; Heslin, M; Knapp, M; Bull, P; Thompson, A; (2008) Multiple Sclerosis in the UK Service Use, Costs, Quality of Life and Disability. PHARMACOECONOMICS , 26 (10) 847 - 860.

McDonald, WI; Compston, A; Edan, G; Goodkin, D; Hartung, HP; Lublin, FD; ... Wolinsky, JS; + view all (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. ANN NEUROL , 50 (1) 121 - 127.

MCDONALD, WI; MILLER, DH; THOMPSON, AJ; (1994) ARE MAGNETIC-RESONANCE FINDINGS PREDICTIVE OF CLINICAL OUTCOME IN THERAPEUTIC TRIALS IN MULTIPLE-SCLEROSIS - THE DILEMMA OF INTERFERON-BETA. ANN NEUROL , 36 (1) 14 - 18.

Miller, D; Barkhof, F; Montalban, X; Thompson, A; Filippi, M; (2005) Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management. LANCET NEUROLOGY , 4 (6) 341 - 348.

Miller, D; Barkhof, F; Montalban, X; Thompson, A; Filippi, M; (2005) Clinically isolated syndromes suggestive of multiple sclerosis, part 1: natural history, pathogenesis, diagnosis, and prognosis. LANCET NEUROLOGY , 4 (5) 281 - 288.

Miller, DH; Barkhof, F; Berry, I; Kappos, L; Scotti, G; Thompson, AJ; (1992) MRI in monitoring the treatment of multiple sclerosis:concerted action guidelines. Journal of Neurology, Neurosurgery and Psychiatry , 55 978 - ?.

MILLER, DH; BARKHOF, F; BERRY, I; KAPPOS, L; SCOTTI, G; THOMPSON, AJ; (1991) MAGNETIC-RESONANCE-IMAGING IN MONITORING THE TREATMENT OF MULTIPLE-SCLEROSIS - CONCERTED ACTION GUIDELINES. J NEUROL NEUROSUR PS , 54 (8) 683 - 688.

Miller, DH; Barkhof, F; Frank, JA; Parker, GJM; Thompson, AJ; (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. BRAIN , 125 1676 - 1695.

Miller, DH; Leary, SM; Thompson, AJ; (2004) Overview of London trial of intramuscular interferon-beta 1a in primary-progressive multiple sclerosis. MULTIPLE SCLEROSIS , 10 S56 - S57. 10.1191/1352458504ms1031oa.

Miller, DH; Thompson, AJ; (1999) Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis. PHILOS T R SOC B , 354 (1390) 1687 - 1695.

Miller, DH; Thompson, AJ; Filippi, M; (2003) Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. JOURNAL OF NEUROLOGY , 250 (12) 1407 - 1419. 10.1007/s00415-003-0243-9.

Miller, DH; Thompson, AJ; Kappos, L; (2001) MRI and assessment of treatment in multiple sclerosis. BRAIN , 124 1052 - 1053.

MILLER, DH; THOMPSON, AJ; MORRISSEY, SP; MACMANUS, DG; MOORE, SG; KENDALL, BE; ... MCDONALD, WI; + view all (1992) HIGH-DOSE STEROIDS IN ACUTE RELAPSES OF MULTIPLE-SCLEROSIS - MRI EVIDENCE FOR A POSSIBLE MECHANISM OF THERAPEUTIC EFFECT. J NEUROL NEUROSUR PS , 55 (6) 450 - 453.

Molyneux, PD; Barker, GJ; Barkhof, F; Beckmann, K; Dahlke, F; Filippi, M; ... European Study Grp Interferon Beta,; + view all (2001) Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS. NEUROLOGY , 57 (12) 2191 - 2197.

Molyneux, PD; Kappos, L; Polman, C; Pozzilli, C; Barkhof, F; Filippi, M; ... European Study Grp Interferon Bet,; + view all (2000) The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. BRAIN , 123 2256 - 2263.

Montalban, X; Sastre-Garriga, J; Filippi, M; Khaleeli, Z; Tellez, N; Vellinga, MM; ... Thompson, AJ; + view all (2009) Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. MULT SCLER , 15 (12) 1459 - 1465. 10.1177/1352458509348422.

Montalban, X; Thompson, AJ; (2002) Workshop on primary progressive multiple sclerosis: meeting summary. Multiple Sclerosis , 8 (2) 177 - 178.

Montalban, X; Tintore, M; Swanton, J; Barkhof, F; Fazekas, F; Filippi, M; ... Miller, DH; + view all (2010) MRI criteria for MS in patients with clinically isolated syndromes. NEUROLOGY , 74 (5) 427 - 434. 10.1212/WNL.0b013e3181cec45c.

Morley, D; Selai, C; Schrag, A; Jahanshahi, M; Thompson, A; (2011) Adolescent and adult children of parents with Parkinson's disease: incorporating their needs in clinical guidelines. Parkinsons Dis , 2011 951874 - ?. 10.4061/2011/951874. Gold open access

Morley, D; Selai, C; Schrag, A; Thompson, AJ; Jahanshahi, M; (2010) Refinement and validation of the Parental Illness Impact Scale. PARKINSONISM RELAT D , 16 (3) 181 - 185. 10.1016/j.parkreldis.2009.11.001.

Morley, D; Selai, C; Thompson, A; (2012) The self-report Barthel Index: preliminary validation in people with Parkinson's disease. Eur J Neurol , 19 (6) 927 - 929. 10.1111/j.1468-1331.2011.03592.x.

Muhlert, N; Atzori, M; De Vita, E; Thomas, DL; Samson, RS; Wheeler-Kingshott, CA; ... Ciccarelli, O; + view all (2014) Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions. J Neurol Neurosurg Psychiatry 10.1136/jnnp-2013-306662.

NAUTA, JJP; THOMPSON, AJ; BARKHOF, F; MILLER, DH; (1994) MAGNETIC-RESONANCE-IMAGING IN MONITORING THE TREATMENT OF MULTIPLE-SCLEROSIS PATIENTS - STATISTICAL POWER OF PARALLEL-GROUPS AND CROSSOVER DESIGNS. J NEUROL SCI , 122 (1) 6 - 14.

Nicholas, R; Playford, ED; Thompson, AJ; (2000) A retrospective analysis of outcome in severe Guillain-Barre syndrome following combined neurological and rehabilitation management. DISABIL REHABIL , 22 (10) 451 - 455.

O'Connor, R; Cano, SJ; Torrenta, LRI; Thompson, AJ; Playford, ED; (2005) Factors influencing work retention for people with multiple sclerosis - Cross-sectional studies using qualitative and quantitative methods. J NEUROL , 252 (8) 892 - 896. 10.1007/s00415-005-0765-4.

O'Connor, RJ; Cano, SJ; Thompson, AJ; Hobart, JC; (2004) Exploring rating scale responsiveness - Does the total score reflect the sum of its parts? NEUROLOGY , 62 (10) 1842 - 1844.

O'Connor, RJ; Cano, SJ; Thompson, AJ; Playford, ED; (2005) The impact of inpatient neurorehabilitation on psychological well-being on discharge and at 3 month follow-up. J NEUROL , 252 (7) 814 - 819. 10.1007/s00415-005-0751-x.

O'Riordan, JI; Losseff, NA; Phatouros, C; Thompson, AJ; Moseley, IF; MacManus, DG; ... Miller, DH; + view all (1998) Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination. J NEUROL NEUROSUR PS , 64 (3) 353 - 357.

O'Riordan, JI; Thompson, AJ; Kingsley, DPE; MacManus, DG; Kendall, BE; Rudge, P; ... Miller, DH; + view all (1998) The prognostic value of brain MRI in clinically isolated syndromes of the CNS - A 10-year follow-up. BRAIN , 121 495 - 503.

O’Connor, R.J.; Cano, S.J.; Thompson, A.J.; Hobart, J.C.; (2004) Exploring rating scale responsiveness: does the total score reflect the sum of its parts? Neurology , 62 (10) pp. 1842-1844.

ORiordan, JI; Gallagher, HL; Thompson, AJ; Howard, RS; Kingsley, DPE; Thompson, EJ; ... Miller, DH; + view all (1996) Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J NEUROL NEUROSUR PS , 60 (4) 382 - 387.

Panchani, J; Adjei, P; Henneberger, C; Scott, CA; Thompson, AJ; Diehl, B; ... Surges, R; + view all (2011) Asymmetric hemispheric representation of periictal heart rate modulation is individually lateralised. EPILEPTIC DISORD , 13 (2) 172 - 176. 10.1684/epd.2011.0430.

Papadopoulos, K; Tozer, DJ; Fisniku, L; Altmann, DR; Davies, G; Rashid, W; ... Chard, DT; + view all (2010) T1-relaxation time changes over five years in relapsing-remitting multiple sclerosis. MULT SCLER , 16 (4) 427 - 433. 10.1177/1352458509359924.

Patti, F; Ciancio, MR; Cacopardo, M; Reggio, E; Fiorilla, T; Palermo, F; ... Thompson, AJ; + view all (2003) Effects of a short outpatient rehabilitation treatment on disability of multiple sclerosis patients - A randomised controlled trial. J NEUROL , 250 (7) 861 - 866. 10.1007/s00415-003-1097-x.

Paty, DW; Goodkin, D; Thompson, A; Rice, G; (1996) Guidelines for physicians with patients on IFN beta-1b: The use of an assay for neutralizing antibodies (NAB). NEUROLOGY , 47 (4) 865 - 866.

Penny, S; Khaleeli, Z; Cipolotti, L; Thompson, A; Ron, M; (2010) Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis. NEUROLOGY , 74 (7) 545 - 552.

Pfennings, L; Cohen, L; Miller, D; Gerbaud, L; Vleugels, L; Freeman, J; ... van der Ploeg, H; + view all (1999) Using the short form-36 with multiple sclerosis patients in five countries: A cross-cultural comparison. PSYCHOL REP , 85 (1) 19 - 31.

Playford, ED; Rossiter, D; Werring, DJ; Thompson, AJ; (1997) Integrated care pathways: evaluating inpatient rehabilitation in stroke. British Journal of Therapy and Rehabilitation , 4 97 - 102.

Playford, ED; Sachs, R; Thompson, AJ; (2002) Integrated care pathways: outcome from inpatient rehabilitation following nontraumatic spinal cord lesion. CLIN REHABIL , 16 (3) 269 - 275. 10.1191/0269215502cr490oa.

Polman, C; Kappos, L; White, R; Dahlke, F; Beckmann, K; Pozzilli, C; ... European Study Grp Interferon,; + view all (2003) Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1b. NEUROLOGY , 60 (1) 37 - 43.

Polman, CH; Dahlke, F; Thompson, AJ; Ghazi, M; Kappos, L; Miltenburger, C; Pozzilli, C; (1995) Inteferon beta-1b in secondary progressive multiple sclerosis - outline of the clinical trial. Multiple Sclerosis , 1 S51 - S54.

Polman, CH; Kappos, L; Dahlke, F; Graf, R; Beckmann, K; Bogumil, T; ... European Study Grp Interferon Beta,; + view all (2005) Interferon beta-1b treatment does not induce autoantibodies. NEUROLOGY , 64 (6) 996 - 1000.

Polman, CH; Kappos, L; Petkau, J; Thompson, A; (2003) Neutralising antibodies to interferon beta during the treatment of multiple sclerosis. J NEUROL NEUROSUR PS , 74 (8) 1162 - 1162.

Polman, CH; Miller, DH; McDonald, WI; Thompson, AJ; (1999) Treatment recommendations for interferon-beta in multiple sclerosis. J NEUROL NEUROSUR PS , 67 (5) 561 - 564.

Polman, CH; Reingold, SC; Banwell, B; Clanet, M; Cohen, JA; Filippi, M; ... Wolinsky, JS; + view all (2011) Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria. ANN NEUROL , 69 (2) 292 - 302. 10.1002/ana.22366.

Polman, CH; Reingold, SC; Barkhof, F; Calabresi, PA; Clanet, M; Cohen, JA; ... Wolinsky, JS; + view all (2008) Ethics of placebo-controlled clinical trials in multiple sclerosis - A reassessment. NEUROLOGY , 70 (13) 1134 - 1140.

Polman, CH; Reingold, SC; Edan, G; Filippi, M; Hartung, HP; Kappos, L; ... Wolinsky, JS; + view all (2005) Diagnostic criteria for multiple sclerosis: 2005 Revisions to the "McDonald Criteria". ANN NEUROL , 58 (6) 840 - 846. 10.1002/ana.206703.

Porter, B; Keenan, E; Record, E; Thompson, AJ; (2003) Diagnosis of MS: a comparison of three different clinical settings. MULT SCLER , 9 (5) 431 - 439. 10.1191/1352458503ms940oa.

Porter, B; Thompson, A; (2012) Connecting to the future - the promise of telecare. MULTIPLE SCLEROSIS JOURNAL , 18 (4) 384 - 386. 10.1177/1352458512441273.

Pryce, G; Ahmed, Z; Hankey, DJR; Jackson, SJ; Croxford, JL; Pocock, JM; ... Baker, D; + view all (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. BRAIN , 126 2191 - 2202. 10.1093/brain/awg224.

Pryce, G.; Ahmed, Z.; Hankey, D.J.R.; Jackson, S.J.; Croxford, J.L.; Pocock, J.M.; ... Baker, D.; + view all (2003) Cannabinoids inhibit neurodegeneration in models of multiple sclerosis. Brain , 126 (10) pp. 2191-2202. 10.1093/brain/awg224.

RAKHIT, RD; BECK, R; FOSTER, O; THOMPSON, AJ; KENDALL, B; (1993) RESOLUTION OF LOWER-LIMB NEUROLOGICAL DEFICIT WITH PENILE PAPAVERINE IN SPINAL ARTERIOVENOUS MALFORMATION. LANCET , 341 (8843) 490 - 490.

Ramdharry, GM; Marsden, JF; Day, BL; Thompson, AJ; (2006) De-stabilizing and training effects of foot orthoses in multiple sclerosis. MULT SCLER , 12 (2) 219 - 226. 10.1191/135248506ms1266oa.

Ramio-Torrenta, L; Sastre-Garriga, J; Ingle, GT; Davies, GR; Ameen, V; Miller, DH; Thompson, AJ; (2006) Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J NEUROL NEUROSUR PS , 77 (1) 40 - 45. 10.1136/jnnp.2004.052316. Gold open access

Ramnani, N; Behrens, TEJ; Johansen-Berg, H; Richter, MC; Pinsk, MA; Andersson, JLR; ... Matthews, PM; + view all (2006) The evolution of prefrontal inputs to the cortico-pontine system: Diffusion imaging evidence from macaque monkeys and humans. CEREB CORTEX , 16 (6) 811 - 818. 10.1093/cercor/bhj024.

Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Gordon, R; ... Miller, DH; + view all (2006) Upper cervical cord area in early relapsing-remitting multiple sclerosis: Cross-sectional study of factors influencing cord size. J MAGN RESON IMAGING , 23 (4) 473 - 476. 10.1002/jmri-i.20545.

Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Gordon, R; ... Miller, DH; + view all (2006) Upper cervical cord area in early relapsing-remitting multiple sclerosis: Cross-sectional study of factors influencing cord size. J MAGN RESON IMAGING , 23 (4) 473 - 476. 10.1002/jmri-i.20545.

Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Gordon, R; ... Miller, DH; + view all (2006) Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. J NEUROL NEUROSUR PS , 77 (1) 51 - 55. 10.1136/jnnp.2005.068338. Gold open access

Rashid, W; Davies, GR; Chard, DT; Griffin, CM; Altmann, DR; Thompson, AJ; Miller, DH; (2007) Relationship of triple dose contrast enhanced lesions with clinical measures and brain atrophy in early relapsing-remitting multiple sclerosis: a two-year longitudinal study. MULT SCLER , 13 (2) 178 - 185. 10.1177/1352458506070758.

Rashid, W; Hadjiprocopis, A; Davies, G; Griffin, C; Chard, D; Tiberio, M; ... Miller, D; + view all (2008) Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging. J NEUROL , 255 (3) 390 - 397. 10.1007/s00415-008-0678-0.

Rashid, W; Hadjiprocopis, A; Griffin, CM; Chard, DT; Davies, GR; Barker, GJ; ... Miller, DH; + view all (2004) Diffusion tensor imaging of early relapsing-remitting multiple sclerosis with histogram analysis using automated segmentation and brain volume correction. MULT SCLER , 10 (1) 9 - 15. 10.1191/1352458504ms985oa.

Rashid, W; Parkes, LM; Ingle, GT; Chard, DT; Toosy, AT; Altmann, DR; ... Miller, DH; + view all (2004) Abnormalities of cerebral perfusion in multiple sclerosis. J NEUROL NEUROSUR PS , 75 (9) 1288 - 1293. 10.1136/jnnp.2003.026021.

Reingold, SC; Steiner, JP; Polman, CH; Cohen, JA; Freedman, MS; Kappos, L; ... Wolinsky, JS; + view all (2009) The challenge of follow-on biologics for treatment of multiple sclerosis. NEUROLOGY , 73 (7) 552 - 559. 10.1212/WNL.0b013e3181b2a6ce.

Rejdak, K; Leary, SM; Nelissen, I; Opdenakker, G; Dubois, B; Thompson, AJ; Giovannoni, G; (2004) Urinary neopterin is a sensitive marker of longitudinal interferon beta-1a treatment in primary progressive multiple sclerosis patients. EUR J NEUROL , 11 120 - 120.

Rejdak, K; Leary, SM; Petzold, A; Thompson, AJ; Miller, DH; Giovannoni, G; (2010) Urinary neopterin and nitric oxide metabolites as markers of interferon beta-1a activity in primary progressive multiple sclerosis. MULT SCLER , 16 (9) 1066 - 1072. 10.1177/1352458510375100.

REVESZ, T; KIDD, D; THOMPSON, AJ; BARNARD, RO; MCDONALD, WI; (1994) A COMPARISON OF THE PATHOLOGY OF PRIMARY AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS. BRAIN , 117 759 - 765.

Riazi, A; Hobart, JC; Fitzpatrick, R; Freeman, JA; Thompson, AJ; (2003) Socio-demographic variables are limited predictors of health status in multiple sclerosis. J NEUROL , 250 (9) 1088 - 1093. 10.1007/s00415-003-0160-y.

Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Freeman, JA; Jenkinson, C; ... Thompson, AJ; + view all (2003) Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles. J NEUROL NEUROSUR PS , 74 (6) 710 - 714.

Riazi, A; Hobart, JC; Lamping, DL; Fitzpatrick, R; Thompson, AJ; (2002) Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry , 73 (6) 701 - 704.

Riazi, A; Porter, B; Chataway, J; Thompson, AJ; Hobart, JC; (2011) A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS). HEALTH QUAL LIFE OUT , 9 , Article 80. 10.1186/1477-7525-9-80. Gold open access

Riazi, A; Thompson, AJ; Hobart, JC; (2004) Self-efficacy predicts self-reported health status in multiple sclerosis. MULT SCLER , 10 (1) 61 - 66. 10.1191/1352458504ms986oa.

Richardson, D; Edwards, S; Sheean, GL; Greenwood, RJ; Thompson, AJ; (1997) The effect of botulinum toxin on hand function after incomplete spinal cord injury at the level of C5/6: a case report. CLIN REHABIL , 11 (4) 288 - 292.

Richardson, D; Greenwood, R; Sheean, G; Thompson, A; Edwards, S; (2000) Treatment of focal spasticity with botulinum toxin: effect on the 'positive support reaction'. Physiother Res Int , 5 (1) 62 - 70.

Richardson, D; Sheean, G; Werring, D; Desai, M; Edwards, S; Greenwood, R; Thompson, A; (2000) Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J NEUROL NEUROSUR PS , 69 (4) 499 - 506.

Richardson, D; Thompson, AJ; (1999) Botulinum toxin: its use in the treatment of acquired spasticity in adults. Physiotherapy , 85 (10) 541 - 551.

Richardson, D; Thompson, AJ; (1999) Management of spasticity in hereditary spastic paraplegia. Physiotherapy Research International , 4 (1) 68 - 76.

Rocca, MA; Absinta, M; Valsasina, P; Ciccarelli, O; Marino, S; Rovira, A; ... Filippi, M; + view all (2009) Abnormal Connectivity of the Sensorimotor Network in Patients With MS: A MultiCenter fMRI Study. HUM BRAIN MAPP , 30 (8) 2412 - 2425. 10.1002/hbm.20679.

Rocca, MA; Absinta, M; Valsasina, P; Ciccarelli, O; Marino, S; Rovira, A; ... Filippi, M; + view all (2009) Abnormal connectivity of the sensorimotor network in patients with MS: A multicenter fMRI study. Human Brain Mapping , 30 (8) 2412 - 2425. 10.1002/hbm.20679.

Rocca, MA; Agosta, F; Sormani, MP; Fernando, K; Tintore, M; Korteweg, T; ... Filippi, M; + view all (2008) A three-year, multi-parametric MRI study in patients at presentation with CIS. J NEUROL , 255 (5) 683 - 691. 10.1007/s00415-008-0776-z.

ROSSITER, D; THOMPSON, AJ; (1995) INTRODUCTION OF INTEGRATED CARE PATHWAYS FOR PATIENTS WITH MULTIPLE-SCLEROSIS IN AN INPATIENT NEUROREHABILITATION SETTING. DISABIL REHABIL , 17 (8) 443 - 448.

Rossiter, D; Thompson, AJ; (1995) Integrated care pathways and their role in the clinical audit of rehabilitation for people with multiple sclerosis. MS Management , 2 (2) 1, 9 - 1,18.

Rossiter, DA; Edmondson, A; Al-Shahi, R; Thompson, AJ; (1998) Integrated care pathways in multiple sclerosis rehabilitation: completing the audit cycle. MULT SCLER , 4 (2) 85 - 89.

Rovaris, M; Barkhof, F; Calabrese, M; De Stefano, N; Fazekas, F; Miller, DH; ... Filippi, M; + view all (2009) MRI features of benign multiple sclerosis Toward a new definition of this disease phenotype. NEUROLOGY , 72 (19) 1693 - 1701. 10.1212/WNL.0b013e3181a55feb.

Rovaris, M; Barnes, D; Woodrofe, N; duBoulay, GH; Thorpe, JW; Thompson, AJ; ... Miller, DH; + view all (1996) Patterns of disease activity in multiple sclerosis patients: A study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups. J NEUROL , 243 (7) 536 - 542.

Rovaris, M; Judica, E; Sastre-Garriga, J; Rovira, A; Sormani, MP; Benedetti, B; ... Filippi, M; + view all (2008) Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. MULT SCLER , 14 (4) 455 - 464. 10.1177/1352458507085129.

Rozewicz, L; Langdon, DW; Davie, CA; Thompson, AJ; Ron, M; (1996) Resolution of left hemisphere cognitive dysfunction in multiple sclerosis with magnetic resonance correlates: a case report. Cogn Neuropsychiatry , 1 (1) 17 - 26. 10.1080/135468096396677.

Rudick, R; Antel, J; Confavreux, C; Cutter, G; Ellison, G; Fischer, J; ... Willoughby, E; + view all (1997) Recommendations from the national multiple sclerosis society clinical outcomes assessment task force. ANN NEUROL , 42 (3) 379 - 382.

Rudick, R; Antel, J; Confavreux, C; Cutter, G; Ellison, G; Fischer, J; ... Willoughby, E; + view all (1996) Clinical outcomes assessment in multiple sclerosis. Annals of Neurology , 40 469 - 479.

Sailer, M; Losseff, NA; Wang, L; Gawne-Cain, ML; Thompson, AJ; Miller, DH; (2001) T1 lesion load and cerebral atrophy as a marker for clinical progression in patients with multiple sclerosis. A prospective 18 months follow-up study. EUR J NEUROL , 8 (1) 37 - 42.

Sailer, M; O'Riordan, JI; Thompson, AJ; Kingsley, DP; MacManus, DG; McDonald, WI; Miller, DH; (1999) Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. NEUROLOGY , 52 (3) 599 - 606.

Sastre-Garriga, J; Galan-Cartana, I; Montalban, X; Thompson, A; (2005) Neurorehabilitation in multiple sclerosis. NEUROLOGIA , 20 (5) 245 - 254.

Sastre-Garriga, J; Galan-Cartana, I; Montalban, X; Thompson, A; (2005) Neurorehabilitation in multiple sclerosis [Neurorrehabilitaci½n en esclerosis mœltiple]. Neurologia , 20 (5) 245 - 254.

Sastre-Garriga, J; Ingle, GT; Chard, DT; Cercignani, M; Ramio-Torrenta, L; Miller, DH; Thompson, AJ; (2005) Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. BRAIN , 128 1454 - 1460. 10.1093/brain/awh498.

Sastre-Garriga, J; Ingle, GT; Chard, DT; Ramio-Torrenta, L; McLean, MA; Miller, DH; Thompson, AJ; (2005) Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. ARCH NEUROL-CHICAGO , 62 (4) 569 - 573.

Sastre-Garriga, J; Ingle, GT; Chard, DT; Ramio-Torrenta, L; Miller, DH; Thompson, AJ; (2004) Grey and white matter atropy in early clinical stages of primary progressive multiple sclerosis. NEUROIMAGE , 22 (1) 353 - 359. 10.1016/j.neuroimage.2004.02.008.

Sastre-Garriga, J; Ingle, GT; Rovaris, M; Tellez, N; Jasperse, B; Altmann, DR; ... Thompson, AJ; + view all (2005) Long-term clinical outcome of primary progressive MS: Predictive value of clinical and MRI data. NEUROLOGY , 65 (4) 633 - 635.

Sastre-Garriga, J; Tintor,; M, R; A, N; C, RO; J, T; ... X,; + view all (2004) Specificity of Barkhof criteria in predicting conversion to multiple sclerosis when applied to clinically isolated brainstem syndromes. Archives of Neurology , 61 (2) 222 - 224.

Sastre-Garriga, J; Tintore, M; Rovira, A; Grive, E; Pericot, I; Comabella, M; ... Montalban, X; + view all (2003) Conversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fluid and neurophysiological findings. MULT SCLER , 9 (1) 39 - 43. 10.1191/1352458503ms847oa.

Schofield, TM; Penny, WD; Stephan, KE; Crinion, JT; Thompson, AJ; Price, CJ; Leff, AP; (2012) Changes in auditory feedback connections determine the severity of speech processing deficits after stroke. J Neurosci , 32 (12) 4260 - 4270. 10.1523/JNEUROSCI.4670-11.2012. Gold open access

Schwartz, MS; Swash, M; Ingram, DAM; Davis, GR; Thompson, AJ; Thakkar, C; Hart, G; (1988) Patterns of selective involvement of thigh muscles in neuromuscular disease. Muscle and Nerve , 11 1240 - 1245.

Scrutton, J; Edwards, S; Sheean, G; Thompson, A; (1996) A little bit of toxin does you good? Physiotherapy Research International , 1 (3) 141 - 147.

Seewann, A; Enzinger, C; Filippi, M; Barkhof, F; Rovira, A; Gass, A; ... Magnims Network,; + view all (2008) MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain - A review of reported findings. J NEUROL , 255 (1) 1 - 10. 10.1007/s00415-007-0754-x.

Sepulcre, J; Sastre-Garriga, J; Cercignani, M; Ingle, GT; Miller, DH; Thompson, AJ; (2006) Regional gray matter atrophy in early primary progressive multiple sclerosis - A voxel-based morphometry study. ARCH NEUROL-CHICAGO , 63 (8) 1175 - 1180.

Serrien, DJ; Strens, LHA; Cassidy, MJ; Thompson, AJ; Brown, P; (2004) Functional significance of the ipsilateral hemisphere during movement of the affected hand after stroke. EXP NEUROL , 190 (2) 425 - 432. 10.1016/j.expneurol.2004.08.004.

Sheean, GL; Murray, NMF; Rothwell, JC; Miller, DH; Thompson, AJ; (1998) An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis. BRAIN , 121 967 - 975.

Sheean, GL; Murray, NMF; Rothwell, JC; Miller, DH; Thompson, AJ; (1997) An electrophysiological study of the mechanism of fatigue in multiple sclerosis. BRAIN , 120 299 - 315.

Silver, NC; Barker, GJ; Losseff, NA; GawneCain, ML; MacManus, DG; Thompson, AJ; Miller, DH; (1997) Magnetisation transfer ratio measurement in the cervical spinal cord: A preliminary study in multiple sclerosis. NEURORADIOLOGY , 39 (6) 441 - 445.

Silver, NC; Good, CD; Barker, GJ; MacManus, DG; Thompson, AJ; Moseley, IF; ... Miller, DH; + view all (1997) Sensitivity of contrast enhanced MRI in multiple sclerosis - Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. BRAIN , 120 1149 - 1161.

Silver, NC; Good, CD; Sormani, MP; MacManus, DG; Thompson, AJ; Filippi, M; Miller, DH; (2001) A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis. J NEUROL , 248 (3) 215 - 224.

Silver, NC; Tofts, PS; Symms, MR; Barker, GJ; Thompson, AJ; Miller, DH; (2001) Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-brain barrier integrity in multiple sclerosis: a preliminary study. MULT SCLER , 7 (2) 75 - 82.

Simon, JH; Thompson, AJ; (2003) Is multiple sclerosis still a clinical diagnosis? NEUROLOGY , 61 (5) 596 - 597.

Sormani, MP; Bruzzi, P; Beckmann, K; Kappos, L; Miller, DH; Polman, C; ... Filippi, M; + view all (2005) The distribution of magnetic resonance imaging response to interferon beta-1b in multiple sclerosis. J NEUROL , 252 (12) 1455 - 1458. 10.1007/s00415-005-0885-x.

Stevenson, VL; GawneCain, ML; Barker, GJ; Thompson, AJ; Miller, DH; (1997) Imaging of the spinal cord and brain in multiple sclerosis: A comparative study between fast flair and fast spin echo. J NEUROL , 244 (2) 119 - 124.

Stevenson, VL; Ingle, GT; Miller, DH; Thompson, AJ; (2004) Magnetic resonance imaging predictors of disability in primary progressive multiple sclerosis: a 5-year study. MULT SCLER , 10 (4) 398 - 401. 10.1191/1352458504ms1055oa.

Stevenson, VL; Leary, SM; Losseff, NA; Parker, GJM; Barker, GJ; Husmani, Y; ... Thompson, AJ; + view all (1998) Spinal cord atrophy and disability in MS - A longitudinal study. NEUROLOGY , 51 (1) 234 - 238.

Stevenson, VL; Miller, DH; Leary, SM; Rovaris, M; Barkhof, F; Brochet, B; ... Thompson, AJ; + view all (2000) One year follow up study of primary and transitional progressive multiple sclerosis. J NEUROL NEUROSUR PS , 68 (6) 713 - 718.

Stevenson, VL; Miller, DH; Rovaris, M; Barkhof, F; Brochet, B; Dousset, V; ... Thompson, AJ; + view all (1999) Primary and transitional progressive MS - A clinical and MRI cross-sectional study. NEUROLOGY , 52 (4) 839 - 845.

Stevenson, VL; Moseley, IF; Phatouros, CC; MacManus, D; Thompson, AJ; Miller, DH; (1998) Improved imaging of the spinal cord in multiple sclerosis using three-dimensional fast spin echo. NEURORADIOLOGY , 40 (7) 416 - 419.

Stevenson, VL; Parker, GJM; Barker, GJ; Birnie, K; Tofts, PS; Miller, DH; Thompson, AJ; (2000) Variations in T1 and T2 relaxation times of normal appearing white matter and lesions in multiple sclerosis. J NEUROL SCI , 178 (2) 81 - 87.

Stevenson, VL; Playford, ED; Langdon, DW; Thompson, AJ; (1996) Rehabilitation of incomplete spinal cord pathology factors affecting prognosis and outcome. J NEUROL , 243 (9) 644 - 647.

Stevenson, VL; Smith, SM; Matthews, PM; Miller, DH; Thompson, AJ; (2002) Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy. J NEUROL , 249 (2) 171 - 177.

Stevenson, VL; Thompson, AJ; (1998) The management of multiple sclerosis: Current and future therapies. DRUG TODAY , 34 (3) 267 - 282.

STEWART, G; KIDD, D; THOMPSON, AJ; (1995) THE ASSESSMENT OF HANDICAP - AN EVALUATION OF THE ENVIRONMENTAL STATUS SCALE. DISABIL REHABIL , 17 (6) 312 - 316.

Strens, LHA; Asselman, P; Pogosyan, A; Loukas, C; Thompson, AJ; Brown, P; (2004) Corticocortical coupling in chronic stroke - Its relevance to recovery. NEUROLOGY , 63 (3) 475 - 484.

Stroman, PW; Wheeler-Kingshott, C; Bacon, M; Schwab, JM; Bosma, R; Brooks, J; ... Tracey, I; + view all (2013) The current state-of-the-art of spinal cord imaging: Methods. Neuroimage 10.1016/j.neuroimage.2013.04.124.

Swanton, JK; Fernando, K; Dalton, CM; Miszkiel, KA; Thompson, AJ; Plant, GT; Miller, DH; (2006) Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J NEUROL NEUROSUR PS , 77 (7) , Article 830. 10.1136/jnnp.2005.073247. Gold open access

Swanton, JK; Fernando, K; Dalton, CM; Miszkiel, KA; Thompson, AJ; T Plant, G; Miller, DH; (2006) Is the frequency of abnormalities on magnetic resonance imaging in isolated optic neuritis related to the prevalence of multiple sclerosis? A global comparison. J NEUROL NEUROSUR PS , 77 (9) 1070 - 1072. 10.1136/jnnp.2006.090910. Gold open access

Swanton, JK; Fernando, KT; Dalton, CM; Miszkiel, KA; Altmann, DR; Plant, GT; ... Miller, DH; + view all (2010) Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis. MULT SCLER , 16 (2) 156 - 165. 10.1177/1352458509353650.

Swanton, JK; Fernando, KT; Dalton, CM; Miszkiel, KA; Altmann, DR; Plant, GT; ... Miller, DH; + view all (2009) Early MRI in optic neuritis The risk for disability. NEUROLOGY , 72 (6) 542 - 550. 10.1212/01.wnl.0000341935.41852.82.

Swanton, JK; Rovira, A; Tintore, M; Altmann, DR; Barkhof, F; Filippi, M; ... Miller, DH; + view all (2007) MR1 criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. LANCET NEUROL , 6 (8) 677 - 686. 10.1016/S1474-4422(07)70176-X.

Thompson, A; (2006) Can we quantify the benefits of DMDs in multiple sclerosis? LANCET NEUROL , 5 (4) 290 - 291.

Thompson, A; (2004) Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis. MULTIPLE SCLEROSIS , 10 S2 - S7. 10.1191/1352458504ms1024oa.

Thompson, A; Antel, J; Carroll, W; (2013) Message from the editors. Mult Scler , 19 (1) 2 - ?. 10.1177/1352458512473206.

Thompson, A; Antel, J; Carroll, W; (2010) Untitled. MULT SCLER , 16 (3) 281 - 281. 10.1177/1352458510363837.

THOMPSON, A; BRAZIL, J; HUTCHINSON, M; FEIGHERY, C; (1987) 3 POSSIBLE LABORATORY INDEXES OF DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS. NEUROLOGY , 37 (3) 515 - 519.

THOMPSON, A; HUTCHINSON, M; MANSFIELD, M; MARTIN, EA; (1985) SUSPECTED AND CLINICALLY DEFINITE MULTIPLE-SCLEROSIS - THE RELATIONSHIP BETWEEN CSF IMMUNOGLOBULINS AND CLINICAL COURSE. J NEUROL NEUROSUR PS , 48 (6) 604 - 604.

Thompson, A; Polman, C; (2009) Improving function: a new treatment era for multiple sclerosis? LANCET , 373 (9665) 697 - 698.

Thompson, AJ; (2008) Multiple sclerosis-a global disorder and still poorly managed. LANCET NEUROL , 7 (12) 1078 - 1079.

Thompson, AJ; (2007) Principles of neurorehabilitation and its application to chronic neurological disorders. NEUROLOGIA 1 - 8.

Thompson, AJ; (2007) Promises, promises... ANN NEUROL , 61 (1) 1 - 2. 10.1002/ana.21083.

Thompson, AJ; (2005) Neurorehabilitation in multiple sclerosis: foundations, facts and fiction. CURR OPIN NEUROL , 18 (3) 267 - 271.

Thompson, AJ; (2002) Developing clinical outcome measures in multiple sclerosis: an evolving process. MULT SCLER , 8 (5) 357 - 358. 10.1191/1352458502ms846cd.

Thompson, AJ; (2002) Progress in neurorehabilitation in multiple sclerosis. CURR OPIN NEUROL , 15 (3) 267 - 270.

Thompson, AJ; (2001) Symptomatic management and rehabilitation in multiple sclerosis. J NEUROL NEUROSUR PS , 71 II22 - II27.

Thompson, AJ; (2000) Neurological rehabilitation: from mechanisms to management. J NEUROL NEUROSUR PS , 69 (6) 718 - 722.

Thompson, AJ; (2000) The effectiveness of neurological rehabilitation in multiple sclerosis. J REHABIL RES DEV , 37 (4) 455 - 461. Gold open access

Thompson, AJ; (1999) Inequality in the availability of expensive treatments. J ROY COLL PHYS LOND , 33 (5) 448 - 449.

Thompson, AJ; (1999) Benign multiple sclerosis. J NEUROL NEUROSUR PS , 67 (2) 138 - 138.

Thompson, AJ; (1999) Measuring handicap in multiple sclerosis. MULTIPLE SCLEROSIS , 5 (4) 260 - 262.

Thompson, AJ; (1998) Rehabilitation in multiple sclerosis. EUR J NEUROL , 5 S27 - S28.

Thompson, AJ; (1998) Symptomatic treatment in multiple sclerosis. CURR OPIN NEUROL , 11 (4) 305 - 309.

Thompson, AJ; (1998) Identification of brain atrophy with MRI in MS. MULTIPLE SCLEROSIS , 4 (3) 257 - 259.

Thompson, AJ; (1998) Multiple sclerosis: Rehabilitation measures. SEMIN NEUROL , 18 (3) 397 - 403.

Thompson, AJ; (1998) The use of interferon-  in the treatment of multiple sclerosis: how big a step in the right direction? Current Practice of Medicine , 1 (1) 15 - 17.

Thompson, AJ; (1997) Rehabilitation solutions in Multiple Sclerosis. Schweizer Archiv für Neurologie und Psychiatrie , 148 (5) 182 - 186. Gold open access

Thompson, AJ; (1996) Rehabilitation of progressive neurological disorders: A worthwhile challenge. CURR OPIN NEUROL , 9 (6) 437 - 440.

Thompson, AJ; (1996) Multiple sclerosis: Symptomatic treatment. J NEUROL , 243 (8) 559 - 565.

Thompson, AJ; (1996) Clinical review of multiple sclerosis. CLIN IMMUNOTHER , 5 1 - 11.

THOMPSON, AJ; (1995) THE FUNCTIONAL INDEPENDENCE MEASURE - A COMPARATIVE VALIDITY AND RELIABILITY STUDY - REPLY. DISABIL REHABIL , 17 (8) 456 - 456.

Thompson, AJ; (1994) Management of MS: towards defining a model of care. MS Update , 8 36 - 38.

Thompson, AJ; Baker, D; (2002) Cannabinoids in MS - Potentially useful but not just yet! NEUROLOGY , 58 (9) 1323 - 1324.

THOMPSON, AJ; BRAZIL, J; MARTIN, EA; HUTCHINSON, M; WHELAN, CA; FEIGHERY, C; (1985) SUPPRESSOR T-CELL CHANGES IN ACTIVE MULTIPLE-SCLEROSIS - ANALYSIS WITH 3 DIFFERENT MONOCLONAL-ANTIBODIES. J NEUROL NEUROSUR PS , 48 (10) 1062 - 1064.

THOMPSON, AJ; BRAZIL, J; WHELAN, CA; MARTIN, EA; HUTCHINSON, M; FEIGHERY, C; (1986) PERIPHERAL-BLOOD LYMPHOCYTE-T CHANGES IN MULTIPLE-SCLEROSIS - A MARKER OF DISEASE PROGRESSION RATHER THAN OF RELAPSE. J NEUROL NEUROSUR PS , 49 (8) 905 - 912.

THOMPSON, AJ; BROWN, MM; RIDLEY, A; (1988) ESCHERICHIA-COLI MENINGITIS AND DISSEMINATED STRONGYLOIDIASIS. J NEUROL NEUROSUR PS , 51 (12) 1596 - 1597.

Thompson, AJ; Brown, MM; Swash, M; Thakkar, C; Scholtz, CL; (1988) Autopsy validation of MRI in central pontine myelinolysis. Neuroradiology , 30 175 - 177.

Thompson, AJ; Chandraratna, D; (2013) Multiple Sclerosis International Federation: Stimulating international cooperation in research. Neurology , 81 (20) 1793 - 1795. 10.1212/01.wnl.0000435552.67953.c8.

Thompson, AJ; Colville, PL; Ketelaer, P; Paty, DW; (1994) Long term management of multiple sclerosis. MS Management , 1 (1) 1 - 9.

Thompson, AJ; Giovannoni, G; (2013) Removal of access to alemtuzumab for patients with aggressive multiple sclerosis. BMJ , 346 f275 - ?.

Thompson, AJ; Hobart, JC; (1998) Multiple sclerosis: assessment of disability and disability scales. J NEUROL , 245 (4) 189 - 196.

THOMPSON, AJ; HUTCHINSON, M; (1985) OLIGOCLONAL BANDS IN MULTIPLE-SCLEROSIS - AN INDEX OF DISEASE-ACTIVITY. NEUROLOGY , 35 (10) 1533 - 1533.

THOMPSON, AJ; HUTCHINSON, M; (1984) MYOPATHY IN HYPOKALEMIC PERIODIC PARALYSIS - REVERSAL WITH ACETAZOLAMIDE. IRISH MED J , 77 (6) 171 - 172. Gold open access

THOMPSON, AJ; HUTCHINSON, M; BRAZIL, J; FEIGHERY, C; MARTIN, EA; (1986) A CLINICAL AND LABORATORY STUDY OF BENIGN MULTIPLE-SCLEROSIS. Q J MED , 58 (225) 69 - 80.

Thompson, AJ; Jarrett, L; Lockley, L; Marsden, J; Stevenson, VL; (2005) Clinical management of spasticity. J NEUROL NEUROSUR PS , 76 (4) 459 - 463. 10.1136/jnnp.2004.035972.

Thompson, AJ; Johnston, S; (1994) The management of neurological disease. The Clinician in Management , 3 (2) 4 - 7.

Thompson, AJ; Johnston, S; Harrison, J; Sheil, R; Burnard, S; (1996) Service delivery in multiple sclerosis: the need for co-ordinated community care. MS Management , 4 11 - 18.

Thompson, AJ; Kennard, C; Swash, M; Summers, B; Yuill, GM; Shepherd, DI; ... Hand, J; + view all (1989) Relative efficacy of intravenous methylpresnisolone amd ACTH in the treatment of acute relapse in MS. Neurology , 39 969 - 971.

THOMPSON, AJ; KERMODE, AG; MACMANUS, DG; KENDALL, BE; KINGSLEY, DPE; MOSELEY, IF; MCDONALD, WI; (1990) PATTERNS OF DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS - CLINICAL AND MAGNETIC-RESONANCE-IMAGING STUDY. BRIT MED J , 300 (6725) 631 - 634.

THOMPSON, AJ; KERMODE, AG; MACMANUS, DG; KINGSLEY, DPE; KENDALL, BE; MOSELEY, IF; MCDONALD, WI; (1989) PATHOGENESIS OF PROGRESSIVE MULTIPLE-SCLEROSIS. LANCET , 1 (8650) 1322 - 1323.

THOMPSON, AJ; KERMODE, AG; MOSELEY, IF; MACMANUS, DG; MCDONALD, WI; (1993) SEIZURES DUE TO MULTIPLE-SCLEROSIS - 7-PATIENTS WITH MRI CORRELATIONS. J NEUROL NEUROSUR PS , 56 (12) 1317 - 1320.

THOMPSON, AJ; KERMODE, AG; WICKS, D; MACMANUS, DG; KENDALL, BE; KINGSLEY, DPE; MCDONALD, WI; (1991) MAJOR DIFFERENCES IN THE DYNAMICS OF PRIMARY AND SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS. ANN NEUROL , 29 (1) 53 - 62.

THOMPSON, AJ; MARTIN, EA; (1985) DUMAS, ZOLA, AND THE LOCKED-IN SYNDROME - REPLY. NEUROLOGY , 35 (7) 1087 - 1087.

THOMPSON, AJ; MARTIN, EA; (1985) THE PACINIAN CORPUSCLE AND SHEKLETON,JOHN. NEUROLOGY , 35 (12) 1747 - 1747.

Thompson, AJ; McDonald, WI; (1996) Multiple sclerosis. Medicine (Oxford) , 24 69 - 75.

THOMPSON, AJ; MILLER, D; YOUL, B; MACMANUS, D; MOORE, S; KINGSLEY, D; ... MCDONALD, WI; + view all (1992) SERIAL GADOLINIUM-ENHANCED MRI IN RELAPSING REMITTING MULTIPLE-SCLEROSIS OF VARYING DISEASE DURATION. NEUROLOGY , 42 (1) 60 - 63.

THOMPSON, AJ; MILLER, DH; MACMANUS, DG; MCDONALD, WI; (1990) PATTERNS OF DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS. BRIT MED J , 301 (6742) 44 - 45.

Thompson, AJ; Montalban, X; Barkhof, F; Brochet, B; Filippi, M; Miller, DH; ... McDonald, WI; + view all (2000) Diagnostic criteria for primary progressive multiple sclerosis: A position paper. ANN NEUROL , 47 (6) 831 - 835.

Thompson, AJ; Noseworthy, JH; (1996) New treatments for multiple sclerosis: A clinical perspective. CURR OPIN NEUROL , 9 (3) 187 - 198.

Thompson, AJ; Playford, ED; (2001) Rehabilitation for patients with Parkinson's disease. LANCET , 357 (9254) 410 - 411.

Thompson, AJ; Polman, CH; Miller, DH; McDonald, WI; Brochet, B; Filippi, M; ... DeSa, J; + view all (1997) Primary progressive multiple sclerosis. BRAIN , 120 1085 - 1096.

Thompson, AJ; Richardson, D; Sheehan, G; Desai, M; Werring, D; Edwards, S; Greenwood, R; (1999) Evaluating the role of botulinum toxin type A in adults with focal spasticity. EUR J NEUROL , 6 S75 - S75.

THOMPSON, AJ; SMITH, I; BRENTON, D; YOUL, BD; RYLANCE, G; DAVIDSON, DC; ... LEES, AJ; + view all (1990) NEUROLOGICAL DETERIORATION IN YOUNG-ADULTS WITH PHENYLKETONURIA. LANCET , 336 (8715) 602 - 605.

THOMPSON, AJ; SMITH, I; KENDALL, BE; YOUL, BD; BRENTON, D; (1991) MAGNETIC-RESONANCE-IMAGING CHANGES IN EARLY TREATED PATIENTS WITH PHENYLKETONURIA. LANCET , 337 (8751) 1224 - 1224.

Thompson, AJ; Swash, M; Cox, EL; Ingram, DAM; Gray, A; Schwartz, MS; (1988) Polysaccharide storage myopathy. Muscle and Nerve , 11 349 - 355.

THOMPSON, AJ; TILLOTSON, S; SMITH, I; KENDALL, B; MOORE, SG; BRENTON, DP; (1993) BRAIN MRI CHANGES IN PHENYLKETONURIA - ASSOCIATIONS WITH DIETARY STATUS. BRAIN , 116 811 - 821.

Thompson, AJ; Toosy, AT; Ciccarelli, O; (2010) Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. LANCET NEUROL , 9 (12) 1182 - 1199.

THOMSON, AJ; BRAZIL, J; FEIGHERY, C; WHELAN, A; KELLET, J; MARTIN, EA; HUTCHINSON, M; (1985) CSF MYELIN BASIC-PROTEIN IN MULTIPLE-SCLEROSIS. ACTA NEUROL SCAND , 72 (6) 577 - 583.

THORPE, JW; KIDD, D; KENDALL, BE; TOFTS, PS; BARKER, GJ; THOMPSON, AJ; ... MILLER, DH; + view all (1993) SPINAL-CORD MRI USING MULTIARRAY COILS AND FAST SPIN-ECHO .1. TECHNICAL ASPECTS AND FINDINGS IN HEALTHY-ADULTS. NEUROLOGY , 43 (12) 2625 - 2631.

Thorpe, JW; Kidd, D; Moseley, IF; Kendall, BE; Thompson, AJ; MacMAnus, DG; ... Miller, DH; + view all (1996) Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing remitting multiple sclerosis. NEUROLOGY , 46 (2) 373 - 378.

Thorpe, JW; Kidd, D; Moseley, IF; Thompson, AJ; MacManus, DG; Compston, DAS; ... Miller, DH; + view all (1996) Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. BRAIN , 119 709 - 714.

Thurston, SE; Leigh, RJ; Crawford, T; Thompson, AJ; Kennard, C; (1988) Two distinct deficits of visual tracking caused by ubilateral lesions of cerebral cortex in humans. Annals of Neurology , 23 266 - 273.

Tiberio, M; Chard, DT; Altmann, DR; Davies, G; Griffin, CM; McLean, MA; ... Miller, DH; + view all (2006) Metabolite changes in early relapsing-remitting multiple sclerosis - A two year follow-up study. J NEUROL , 253 (2) 224 - 230. 10.1007/s00415-005-0964-z.

Tiberio, M; Chard, DT; Altmann, DR; Davies, G; Griffin, CM; Rashid, W; ... Miller, DH; + view all (2005) Gray and white matter volume changes in early RRMS - A 2-year longitudinal study. NEUROLOGY , 64 (6) 1001 - 1007.

Toosy, A; Ciccarelli, O; Thompson, A; (2014) Symptomatic treatment and management of multiple sclerosis. Handb Clin Neurol , 122 513 - 562. 10.1016/B978-0-444-52001-2.00023-6.

Toosy, A; Thompson, A; (2000) Multiple sclerosis: The disease and its treatment. Pharmaceutical Journal , 264 (7095) 694 - 700.

Toosy, AT; Ciccarelli, O; Parker, GJM; Wheeler-Kingshott, CAM; Miller, DH; Thompson, AJ; (2004) Characterizing function-structure relationships in the human visual system with functional MRI and diffusion tensor imaging. NEUROIMAGE , 21 (4) 1452 - 1463. 10.1016/j.neuroimage.2003.11.022.

Toosy, AT; Hickman, SJ; Miszkiel, KA; Jones, SJ; Plant, GT; Altmann, DR; ... Thompson, AJ; + view all (2005) Adaptive cortical plasticity in higher visual areas after acute optic neuritis. ANN NEUROL , 57 (5) 622 - 633. 10.1002/ana.20448.

Toosy, AT; Werring, DJ; Bullmore, ET; Plant, GT; Barker, GJ; Miller, DH; Thompson, AJ; (2002) Functional magnetic resonance imaging of the cortical response to photic stimulation in humans following optic neuritis recovery. NEUROSCI LETT , 330 (3) 255 - 259.

Toosy, AT; Werring, DJ; Orrell, RW; Howard, RS; King, MD; Barker, GJ; ... Thompson, AJ; + view all (2003) Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J NEUROL NEUROSUR PS , 74 (9) 1250 - 1257.

Toosy, AT; Werring, DJ; Plant, GT; Bullmore, ET; Miller, DH; Thompson, AJ; (2001) Asymmetrical activation of human visual cortex demonstrated by functional MRI with monocular stimulation. NEUROIMAGE , 14 (3) 632 - 641. 10.1006/nimg.2001.0851.

Tozer, DJ; Chard, DT; Bodini, B; Ciccarelli, O; Miller, DH; Thompson, AJ; Wheeler-Kingshott, CA; (2012) Linking white matter tracts to associated cortical grey matter: a tract extension methodology. Neuroimage , 59 (4) 3094 - 3102. 10.1016/j.neuroimage.2011.10.088.

Tozer, DJ; Marongiu, G; Swanton, JK; Thompson, AJ; Miller, DH; (2009) Texture Analysis of Magnetization Transfer Maps From Patients With Clinically Isolated Syndrome and Multiple Sclerosis. J MAGN RESON IMAGING , 30 (3) 506 - 513. 10.1002/jmri.21885.

Traboulsee, A; Dehmeshki, J; Peters, KR; Griffin, CM; Brex, PA; Silver, N; ... Miller, D; + view all (2003) Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities. MULT SCLER , 9 (6) 566 - 573. 10.1191/1352458503ms958oa.

Trip, S; Schlottmann, PG; Jones, S; Li, WY; Thompson, A; Plont, GT; Miller, DH; (2007) Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis. MULT SCLER , 13 (7) 875 - 879. 10.1177/1352458507076952.

Trip, S.A.; Schlottmann, P.G.; Jones, S.J.; Altmann, D.R.; Garway-Heath, D.F.; Thompson, A.J.; ... Miller, D.H.; + view all (2005) Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Annals of Neurology , 58 (3) pp. 383-391. 10.1002/ana.20575.

Trip, SA; Schlottmann, PG; Jones, SJ; Altmann, DR; Garway-Heath, DF; Thompson, AJ; ... Miller, DH; + view all (2005) Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. ANN NEUROL , 58 (3) 383 - 391. 10.1002/ana.20575.

Trip, SA; Schlottmann, PG; Jones, SJ; Garway-Heath, DF; Thompson, AJ; Plant, GT; Miller, DH; (2006) Quantification of optic nerve head topography in optic neuritis: a pilot study. BRIT J OPHTHALMOL , 90 (9) 1128 - 1131. 10.1136/bjo.2006.092031. Gold open access

Trip, SA; Schlottmann, PG; Jones, SJ; Kallis, C; Altmann, DR; Garway-Heath, DF; ... Miller, DH; + view all (2010) Scanning Laser Polarimetry Quantification of Retinal Nerve Fiber Layer Thinning Following Optic Neuritis. J NEURO-OPHTHALMOL , 30 (3) 235 - 242. 10.1097/WNO.0b013e3181dbfeac.

Trip, SA; Schlottmann, PG; Jones, SJ; Li, WY; Garway-Heath, DF; Thompson, AJ; ... Miller, DH; + view all (2006) Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: Evidence that axonal loss is a substrate of MRI-detected atrophy. NEUROIMAGE , 31 (1) 286 - 293. 10.1016/j.neuroimage.2005.11.051.

Trip, SA; Wheeler-Kingshott, C; Jones, SJ; Li, WY; Barker, GJ; Thompson, AJ; ... Miller, DH; + view all (2006) Optic nerve diffusion tensor imaging in optic neuritis. NEUROIMAGE , 30 (2) 498 - 505. 10.1016/j.neuroimage.2005.09.024.

Tubridy, N; Ader, HJ; Barkhof, F; Thompson, AJ; Miller, DH; (1998) Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groups. J NEUROL NEUROSUR PS , 64 (1) 50 - 55.

Tubridy, N; Coles, AJ; Molyneux, P; Compston, DAS; Barkhof, F; Thompson, AJ; ... Miller, DH; + view all (1998) Secondary progressive multiple sclerosis: the relationship between short-term MRI activity and clinical features. BRAIN , 121 225 - 231.

Tur, C; Khaleeli, Z; Ciccarelli, O; Altmann, DR; Cercignani, M; Miller, DH; Thompson, AJ; (2011) Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS. J NEUROL NEUROSUR PS , 82 (4) 423 - 428. 10.1136/jnnp.2010.209890.

Tur, C; Penny, S; Khaleeli, Z; Altmann, DR; Cipolotti, L; Ron, M; ... Ciccarelli, O; + view all (2011) Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis. MULT SCLER J , 17 (11) 1324 - 1332. 10.1177/1352458511410341.

Tur, C; Wheeler-Kingshott, CA; Altmann, DR; Miller, DH; Thompson, AJ; Ciccarelli, O; (2014) Spatial variability and changes of metabolite concentrations in the cortico-spinal tract in multiple sclerosis using coronal CSI. Hum Brain Mapp , 35 (3) 993 - 1003. 10.1002/hbm.22229.

van der Linden, FAH; Kragt, JJ; Hobart, JC; Klein, M; Thompson, AJ; van der Ploeg, HM; ... Uitdehaag, BMJ; + view all (2009) The size of the treatment effect: do patients and proxies agree? BMC Neurology , 9 , Article 12. 10.1186/1471-2377-9-12. Green and gold open access
file

van der Linden, FAH; Kragt, JJ; Hobart, JC; Klein, M; Thompson, AJ; van der Ploeg, HM; ... Uitdehaag, BMJ; + view all (2006) Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily life. J NEUROL NEUROSUR PS , 77 (10) 1157 - 1162.

van der Linden, FAH; Kragt, JJ; van Bon, M; Klein, M; Thompson, AJ; van der Ploeg, HM; ... Uitdehaag, BMJ; + view all (2008) Longitudinal proxy measurements in multiple sclerosis: patient-proxy agreement on the impact of MS on daily life over a period of two years. BMC Neurology , 8 , Article 2. 10.1186/1471-2377-8-2. Green and gold open access
file

van der Putten, JJMF; Hobart, JC; Freeman, JA; Thompson, AJ; (1999) Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel Index and the Functional Independence Measure. J NEUROL NEUROSUR PS , 66 (4) 480 - 484.

van der Putten, JMF; Stevenson, VL; Playford, ED; Thompson, AJ; (2001) Factors affecting functional outcome in patients with nontraumatic spinal cord lesions after inpatient rehabilitation. NEUROREHAB NEURAL RE , 15 (2) 99 - 104.

van Oosten, BW; Lai, M; Barkhof, F; Miller, DH; Moseley, IF; Thompson, AJ; ... Polman, CH; + view all (1996) A phase II trial of anti-CD4-antibodies in the treatment of multiple sclerosis. Multiple Sclerosis , 1 339 - 342.

van Waesberghe, JHTM; Kamphorst, W; De Groot, CJA; van Walderveen, MAA; Castelijns, JA; Ravid, R; ... Barkhof, F; + view all (1999) Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability. ANN NEUROL , 46 (5) 747 - 754.

van Walderveen, MAA; Barkhof, F; Polman, C; Frequin, STFM; Hommes, OR; Thompson, AJ; Valk, J; (1998) Patterns of brain magnetic resonance abnormalities on T-2-weighted spin echo images in clinical subgroups of multiple sclerosis: A large cross-sectional study. EUR NEUROL , 40 (2) 91 - 98.

vanOosten, BW; Lai, M; Hodgkinson, S; Barkhof, F; Miller, DH; Moseley, IF; ... Polman, CH; + view all (1997) Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. NEUROLOGY , 49 (2) 351 - 357.

Wang, LQ; Lai, HM; Thompson, AJ; Miller, DH; (1997) Survey of the distribution of lesion size in multiple sclerosis: implication for the measurement of total lesion load. J NEUROL NEUROSUR PS , 63 (4) 452 - 455.

Ward, N.S.; Brown, M.M.; Thompson, A.J.; Frackowiak, R.S.J.; (2004) The influence of time after stroke on brain activations during a motor task. Annals of Neurology , 55 (6) pp. 829-834. 10.1002/ana.20099.

Ward, N.S.; Brown, M.M.; Thompson, A.J.; Frackowiak, R.S.J.; (2003) Neural correlates of motor recovery after stroke: a longitudinal fMRI study. Brain , 126 (11) pp. 2476-2496. 10.1093/brain/awg245.

Ward, N.S.; Brown, M.M.; Thompson, A.J.; Frackowiak, R.S.J.; (2003) Neural correlates of outcome after stroke: a cross-sectional fMRI study. Brain , 126 (6) pp. 1430-1448. 10.1093/brain/awg145.

Ward, NS; Brown, MM; Thompson, AJ; Frackowiak, RSJ; (2006) Longitudinal changes in cerebral response to proprioceptive input in individual patients after stroke: An fMRI study. NEUROREHAB NEURAL RE , 20 (3) 398 - 405. 10.1177/1545968306286322.

Ward, NS; Brown, MM; Thompson, AJ; Frackowiak, RSJ; (2004) The influence of time after stroke on brain activations during a motor task. ANN NEUROL , 55 (6) 829 - 834. 10.1002/ana.20099.

Ward, NS; Brown, MM; Thompson, AJ; Frackowiak, RSJ; (2003) Neural correlates of motor recovery after stroke: a longitudinal fMRI study. BRAIN , 126 2476 - 2496. 10.1093/brain/awg245.

Ward, NS; Brown, MM; Thompson, AJ; Frackowiak, RSJ; (2003) Neural correlates of outcome after stroke: a cross-sectional fMRI study. BRAIN , 126 1430 - 1448. 10.1093/brain/awg145.

Ward, NS; Newton, JM; Swayne, OBC; Lee, L; Frackowiak, RSJ; Thompson, AJ; ... Rothwell, JC; + view all (2007) The relationship between brain activity and peak grip force is modulated by corticospinal system integrity after subcortical stroke. EUR J NEUROSCI , 25 (6) 1865 - 1873. 10.1111/j.1460-9568.2007.05434.x.

Ward, NS; Newton, JM; Swayne, OBC; Lee, L; Thompson, AJ; Greenwood, RJ; ... Frackowiak, RSJ; + view all (2006) Motor system activation after subcortical stroke depends on corticospinal system integrity. BRAIN , 129 809 - 819. 10.1093/brain/awl002.

Weatherby, SJM; Mann, CLA; Fryer, AA; Strange, RC; Hawkins, CP; Stevenson, VL; ... Thompson, AJ; + view all (2000) No association between the APOE epsilon 4 allele and outcome and susceptibility in primary progressive multiple sclerosis. J NEUROL NEUROSUR PS , 68 (4) 532 - 532.

Wegner, C; Filippi, M; Korteweg, T; Beckmann, C; Ciccarelli, O; De Stefano, N; ... Matthews, PM; + view all (2008) Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. EUR J NEUROL , 15 (2) 113 - 122. 10.1111/j.1468-1331.2007.02027.x.

Werring, DJ; Brassat, D; Droogan, AG; Clark, CA; Symms, MR; Barker, GJ; ... Miller, DH; + view all (2000) The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis - A serial diffusion MRI study. BRAIN , 123 1667 - 1676.

Werring, DJ; Bullmore, ET; Toosy, AT; Miller, DH; Barker, GJ; MacManus, DG; ... Thompson, AJ; + view all (2000) Recovery from optic neuritis is associated with a change in the distribution of cerebral response to visual stimulation: a functional magnetic resonance imaging study. J NEUROL NEUROSUR PS , 68 (4) 441 - 449.

Werring, DJ; Clark, CA; Barker, GJ; Miller, DH; Parker, GJM; Brammer, MJ; ... Thompson, AJ; + view all (1998) The structural and functional mechanisms of motor recovery: complementary use of diffusion tensor and functional magnetic resonance imaging in a traumatic injury of the internal capsule. J NEUROL NEUROSUR PS , 65 (6) 863 - 869.

Werring, DJ; Clark, CA; Barker, GJ; Thompson, AJ; Miller, DH; (1999) Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. NEUROLOGY , 52 (8) 1626 - 1632.

Werring, DJ; Clark, CA; Droogan, AG; Barker, GJ; Miller, DH; Thompson, AJ; (2001) Water diffusion is elevated in widespread regions of normal-appearing white matter in multiple sclerosis and correlates with diffusion in focal lesions. MULT SCLER , 7 (2) 83 - 89.

Werring, DJ; Clark, CA; Parker, GJM; Miller, DH; Thompson, AI; Barker, GJ; (1999) A direct demonstration of both structure and function in the visual system: Combining diffusion tensor imaging with functional magnetic resonance imaging. NEUROIMAGE , 9 (3) 352 - 361.

Werring, DJ; Thompson, AJ; (1998) Improving the quality of life of patients with multiple sclerosis: Diagnosis. DRUG TODAY , 34 (2) 145 - 156.

Werring, DJ; Toosy, AT; Clark, CA; Parker, GJM; Barker, GJ; Miller, DH; Thompson, AJ; (2000) Diffusion tensor imaging can detect and quantify corticospinal tract degeneration after stroke. J NEUROL NEUROSUR PS , 69 (2) 269 - 272.

Wheeler-Kingshott, C; Stroman, PW; Schwab, JM; Bacon, M; Bosma, R; Brooks, J; ... Tracey, I; + view all (2013) The current state-of-the-art of spinal cord imaging - Applications. Neuroimage 10.1016/j.neuroimage.2013.07.014.

Willison, HJ; O'Leary, CP; Veitch, J; Blumhardt, LD; Busby, M; Donaghy, M; ... Winer, J; + view all (2001) The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. BRAIN , 124 1968 - 1977.

Wolinsky, J; Narayana, PA; O'Connor, P; Coyle, PK; Ford, C; Johnson, K; et al,; (2007) Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial. Annals of Neurology , 61 (1) 14 - 24.

WROE, SJ; THOMPSON, AJ; MCDONALD, WI; (1991) PAINFUL INTRAORBITAL MENINGIOMAS. J NEUROL NEUROSUR PS , 54 (11) 1009 - 1010.

YOUL, BD; KERMODE, AG; THOMPSON, AJ; REVESZ, T; SCARAVILLI, F; BARNARD, RO; ... MCDONALD, WI; + view all (1991) DESTRUCTIVE LESIONS IN DEMYELINATING DISEASE. J NEUROL NEUROSUR PS , 54 (4) 288 - 292.

Zajicek, J; Fox, P; Sanders, H; Wright, D; Vickery, J; Nunn, A; ... UK MS Research Group,; + view all (2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet , 362 (9395) 1517 - 1526. 10.1016/S0140-6736(03)14738-1.

Zajicek, J.; Fox, P.; Sanders, H.; Wright, D.; Vickery, J.; Nunn, A.; Thompson, A.; (2003) Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. The Lancet , 362 (9395) pp. 1517-1526. 10.1016/S0140-6736(03)14738-1.

Zajicek, JP; Sanders, HP; Wright, DE; Vickery, PJ; Ingram, WM; Reilly, SM; ... Thompson, AJ; + view all (2005) Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. Journal of Neurology, Neurosurgery and Psychiatry , 76 (12) 1664 - 1669.

Zarei, M; Johansen-Berg, H; Jenkinson, M; Ciccarelli, O; Thompson, AJ; Matthews, PM; (2007) Two-dimensional population map of cortical connections in the human internal capsule. J MAGN RESON IMAGING , 25 (1) 48 - 54. 10.1002/jmri.20810.

Zarei, M; Johansen-Berg, H; Smith, S; Ciccarelli, O; Thompson, AJ; Matthews, PM; (2006) Functional anatomy of interhemispheric cortical connections in the human brain. J ANAT , 209 (3) 311 - 320. 10.1111/j.1469-7580.2006.00615.x.

ZOUKOS, Y; KIDD, D; WOODROOFE, MN; KENDALL, BE; THOMPSON, AJ; CUZNER, ML; (1994) INCREASED EXPRESSION OF HIGH-AFFINITY IL-2 RECEPTORS AND P-ADRENOCEPTORS ON PERIPHERAL-BLOOD MONONUCLEAR-CELLS IS ASSOCIATED WITH CLINICAL AND MRI ACTIVITY IN MULTIPLE-SCLEROSIS. BRAIN , 117 307 - 315.

ZOUKOS, Y; LEONARD, JP; THOMAIDES, T; THOMPSON, AJ; CUZNER, ML; (1992) BETA-ADRENERGIC-RECEPTOR DENSITY AND FUNCTION OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS ARE INCREASED IN MULTIPLE-SCLEROSIS - A REGULATORY ROLE FOR CORTISOL AND INTERLEUKIN-1. ANN NEUROL , 31 (6) 657 - 662.

Zoukos, Y; Thomaides, TN; Kidd, D; Cuzner, ML; Thompson, A; (2003) Expression of beta(2) adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study. J NEUROL NEUROSUR PS , 74 (2) 197 - 202.

Book

Playford, ED (Ed). (2003) Neurological rehabilitation of Parkinson's Disease. Queen Square Neurological Rehabilitation Series. Martin Dunitz: London.

Polman, CH; Thompson, AJ; Murray, TJ; McDonald, WI; (2001) Multiple sclerosis: the guide to treatment and management. (5th ed.). Demos: New York.

Sailer, M; Bodammer, N; Miller, DH; (2000) Magnetic resonance imaging in multiple sclerosis. (Vol.31). GEORG THIEME VERLAG

Thompson, AJ; (2006) Neurological rehabilitation of multiple sclerosis. Queen Square Neurological Rehabilitation Series. Informa Healthcare: London.

Thompson, AJ; McDonald, WI; (1999) Key advances in the effective management of multiple sclerosis. Royal Society of Medicine: London.

Thompson, AJ; Polman, CH; Hohlfeld, R; (1997) Multiple sclerosis: clinical challenges and controversies. Martin Dunitz: London.

Book chapter

Cano, SJ; Thompson, AJ; How to measure the effects of rehabilitation. In: Kesselring, C and Thompson,, (eds.) Recovery in Multiple Sclerosis.

Dobkin, BH; Thompson, AJ; (2000) Principles of neurological rehabilitation. In: Bradley, WG and Daroff, RB and Fenichel, GM and Marsden, CD, (eds.) Neurology in clinical practice: volume 1. Principles of diagnosis and management. (959 - 1005). Butterworth Heinemann: Oxford.

Foong, J; Rozewicz, L; Thompson, AJ; Miller, DH; Ron, MA; (1997) Frontal lobe disturbances and cognitive functioning in patients with multiple sclerosis. In: Ketelaer, P and Prosiegel, M and Battaglia, M and Messmer Uccelli, M, (eds.) A problem-oriented approach to multiple sclerosis. (88 - 94). Acco: Lueven.

Foong, J; Rozewicz, L; Thompson, AJ; Miller, DH; Ron, MA; (1996) Frontal lobe disturbances and cognitive functioning in patients with multiple sclerosis. In: Prosiegel, M and Vermote, R and Ketelaer, P, (eds.) Neuropsychology and psychology. (45 - 52). AISM Genova: Italy.

Freeman, JA; Thompson, AJ; (2003) Rehabilitation in multiple sclerosis. In: Multiple sclerosis 2. (317 - 328). Butterworth Heinemann

Freeman, JA; Thompson, AJ; (1997) Is inpatient rehabilitation effective in multiple sclerosis? In: Thompson, AJ and Polman, CH and Hohlfeld, R, (eds.) Multiple sclerosis: clinical challenges and controversies. (313 - 324). Martin Dunitz: London.